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The International Association for the Study of Pain (IASP) has defined pain as “an 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage or described in terms of such damage”. This definition reflects pain as a 
complex sensory and subjective experience, which exists in the context of functional, 
physical, psychological, cognitive, emotional and social dimensions. Pain represents a 
major primary healthcare problem and is a very common complaint presented by 
several patients. The focus of our research is on pain management from two 
perspectives:  
(1) Assessment of “preemptive analgesia” for postoperative pain in an animal model 
and a pilot clinical study,  
(2) Survey of the use of Traditional Chinese Medicine (TCM) for ambulatory acute or 
chronic pain management in Singapore. 
 
The effective management of postoperative pain is considered to be a major challenge, 
which often falls short of expectations.  Basic scientific evidence suggests that 
analgesic intervention before surgery may yield a better outcome than the same 
intervention made after surgery. We explored in this study the concept of “preemptive 
analgesia” as, an anti-nociceptive treatment that prevents the establishment of altered 
processing of afferent input that amplifies postoperative pain, by conducting an 
animal study and a small-scale clinical study.  The preemptive analgesic effects of 
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etoricoxib, celecoxib, indomethacin, naproxen and tramadol were studied in a rat 
model of post- incisional pain. The findings thus obtained indicated that animals given 
preoperative administration of these drugs exhibited significantly higher (P< 0.05) 
withdrawal thresholds than that of the placebo control group. Moreover, the effects of 
preoperative administration of etoricoxib, indomethacin, naproxen or tramadol were 
significantly higher (P< 0.05) compared to that of postoperative administration of the 
corresponding drug for a period up to 2 days after the surgery.  
 
A clinical study was then conducted to compare the analgesic efficacies and safety 
profiles of preoperative rofecoxib with preoperative tramadol in patients undergoing 
haemorrhoidectomies at an ambulatory surgical centre.  Both rofecoxib and tramadol 
showed similar analgesic efficacies in this study.  However, tramadol was associated 
with a higher incidence of side effects. 
 
With the growing popularity of Complementary and Alternative Medicine (CAM), a 
study was needed to provide a better understanding of TCM use in pain management. 
A questionnaire was designed and administered to investigate the importance of TCM 
in acute and chronic pain management. The main objective was to establish the 
prevalence of and the common reasons for its use by patients attending consultations 
at two primary healthcare settings – the family/polyclinic and the TCM clinic, where 
the western/conventional medical doctor and the TCM practitioner practiced, 
respectively. This survey, which included 214 respondents (98 from TCM practitioner 
clinic and 116 from polyclinic), revealed that the prevalence of TCM use to treat pain 
problem in the preceding 12 months was approximately 47%, and about half (46.5%) 
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of these respondents, who were mostly Chinese, used TCM as the first- line treatment 
for pain relief. This suggests that TCM is more than just an alternative medicine in 
Singapore, and perhaps also in other countries, where there are ethnic Chinese. 
 
The three different studies described above looked into various aspects in pain 
management. Although some limitations in study design were noted, it serves as a 
platform for further research to provide better understanding in pain management. 
Future study with proper study design, preferably double blind study with 
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Chapter I – Introduction 
 
1.1 General introduction 
Pain hurts and we all have experienced some kind of pain at some times in our lives. 
It serves as an early warning that alerts individual to the presence of damaging stimuli, 
nonetheless persistent pain in most of the cases serves no additional purpose than 
causing excessive stress and suffering.  Several studies have recognized pain as a 
major primary health care problem and it represents the most commonly perceived 
symptom which has an enormous impact on public health. Population studies in 
Finland and Sweden reported pain as the reason for 40% and 30% of visits to primary 
care practice (1, 2). A group of researchers had reported that pain prevalence was as 
high as 78% in the Spanish general population (3).  
 
Pain has been defined by the International Association for the Study of Pain (IASP) as 
“an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage or described in terms of such damage” (4). This definition reflects pain 
as a complex sensory and subjective experience, which exists in the context of 
functional, physical, psychological, cognitive, emotional and social dimensions.  
 
The classification of pain is diverse. According to the nature of pain, it can be roughly 
divided into two groups: physiological pain and clinical pain (5). Physiological pain is 
initiated by specialized sensory nociceptor fibers innervating peripheral tissues and 
activated only by noxious stimuli. It is normally short in duration and represents a 
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warning system for potentially harmful stimuli (5, 6). Clinical pain is initiated by tissue 
damage or inflammation; it is related to activation of the nociceptive afferents as part 
of a disease or trauma (5, 6). On the other hand, from a temporal point of view, pain can 
then be classified as acute and chronic (7, 8). Pain immediately following an injury to 
the body is considered to be acute. It may be self- limiting in some occasions and 
typically subsides when the injury heals. However, acute pain problems are the most 
frequent reasons for patients seeking medical attention and are commonly observed in 
emergency room care, the postoperative setting, obstetric practice, sports medicine 
and the care of trauma and burn patients (9). IASP has defined chronic pain (10) as 
“pain without apparent biological value that has persisted beyond normal tissue 
healing time (usually taken to be 3 months).” Unlike acute pain which instructs the 
individual to avoid further injury or seek help, chronic pain usually serves no benefit 
to the individual. It is often destructive to the host by deteriorating quality of life, 
functional ability, financial status et cetera (7).  
 
Pain sensation involves a series of complex interactions between peripheral nerves 
and the central nervous system (CNS). Nociception, or the sensation of pain, is 
composed of four basic processes: transduction, transmission, modulation, and 
perception. These processes are modulated by excitatory and inhibitory 
neurotransmitters and psychological and physiological responses to stimuli. The goal 
of pain management is to reduce peripheral sensitization, thereby decreasing central 
stimulation and the amplification associated with wind-up, spread, and central 
sensitization. This often requires multiple modalities to interrupt transmission at 
different levels (7, 11). Figure 1.1 shows the various neuronal pathways as well as 
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potential sites for prevention and treatment in pain management (12). Inadequately 
treated pain can induce physiological hormonal responses that alter circulation and 
tissue metabolism; can produce major psychological stress responses and compromise 




Figure 1.1 Neuronal pathways and potential sites for prevention and treatment in pain 
management. Broadly, the potential sites of action are brain; spinal cord neurons; 
dorsal root and peripheral nerve axon; and peripheral nociceptors/inflammatory 
response mediators. Some of the endogenous neurochemical mediators of nociception 
are listed in the figure, which represents potential pharmacologic option in pain 
management (12). 
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1.2 Prevalence of postoperative pain and its impact 
It is widely perceived that pain is part of the package of surgery. Although pain is an 
unavoidable but predictable part of the postoperative experience, inadequate 
management of postoperative pain is common with profound implications (13). Several 
clinical practice guidelines or reports (13-15) for improving postoperative pain 
management are available, but studies continue to show an embarrassing lack of 
progress in this direction. It was noted nearly 30 years ago that approximately 73% of 
patients reported moderate-to-severe pain following medical and surgical procedures 
(16). A Gallup poll conducted in 1995 in United States revealed that 54% of all patients 
reported unsatisfactory postoperative analgesia (17). Another recent United States 
National Survey revealed that approximately 80% of patients experienced acute pain 
after surgery, and about 86% of them reported moderate, severe, or extreme pain. It 
was also noted in the same survey that ‘experiencing postoperative pain’ was the most 
common concern (59%) of patients undergoing surgery (13). 
 
The consequences of poor postoperative pain management are considerable. 
Unrelieved postoperative pain is often associated with clinical and psychological 
changes that have significant impact upon morbidity and mortality, as well as, 
financial costs and quality of life. Furthermore, pain has pathophysiological effect on 
body systems that may lead to an increased incidence of myocardial ischemia, 
atelectasis, and impaired wound healing (13, 16). Therefore a need to develop new 
medications, new multimodal therapies, new dosing strategies and new surgical 
approaches to provide better postoperative pain management is pressing.         
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1.3 The concept of preemptive analgesia 
In the beginning of the last century, Crile was among the first to introduce the concept 
of treating pain prior to its onset: preemptive analgesia (18, 19). Woolf (20, 21)  then paved 
the idea that preemptive analgesia might reduce the magnitude and duration of 
postoperative pain in 1983. Crile advocated the use of regional blocks in addition to 
general anesthesia to prevent intraoperative nociception and the formation of painful 
scars caused by changes in the central nervous system during surgery (19). The 
resurgence of this idea was associated with a series of animal studies started by Woolf, 
who showed evidence for a central component of post- injury pain hypersensitivity in 
experimental studies (20, 21). Initial observations indicated that noxious stimuli induced 
changes in neural function (20, 22), such as hyperexcitability, in the spinal cord. This 
idea was then further highlighted by Wall (23) in a 1988 editorial that drew clinicians’ 
attention because it linked fundamental work to clinical studies (22, 23). The editorial 
related the findings in fundamental studies, the changes in the central nervous system 
that followed nociceptive stimuli and the ways in which these changes could be 
preempted, to clinical work in postoperative pain.  
 
An overwhelming amount of experimental data had demonstrated that various 
antinociceptive techniques applied before injury were more effective in reducing the 
post-injury central sensitization phenomena compared with administration after injury 
(19, 24). This convincing finding in experimental research has triggered many clinical 
studies and systemic reviews of clinical studies (21, 22, 25-30). It is currently concluded 
that although the experimental research provided very promising evidence on 
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preemptive analgesia, results of clinical studies regarding the value of preemptive 
analgesia are still controversial. 
 
The definitions of preemptive analgesia are far from being uniform, and therefore 
cited as the major cause of controversy regarding its clinical relevance (19, 24, 30). There 
are as many as three different definitions employed in the recent clinical trials (19): 
1. Starts before surgery; 
2. Prevents the establishment of central sensitization caused by incisional injury 
(covers only the period of surgery); 
3. Prevents the establishment of central sensitization caused by incisional and 
inflammatory injuries (covers the period of surgery and the initial postoperative 
period). 
 
Kissin has reviewed these definitions and given his support to definition 3 which is 
then widely accepted (19, 30) and thus adopted in our studies. Tissue damage will 
inevitably produce two phases of sensory input, the first will be associated directly 
with the tissue-damaging stimulus, i.e. during surgery, and the second will result from 
the inflammatory reaction to the damaged tissue (25). Since both phases of nociceptor 
input have the capacity to induce altered sensory processing (central sensitization), the 
ideal preemptive treatment, therefore, should cover the entire duration of central 
sensitization, from the primary phase well into the postoperative period (19, 30). The 
most important conditions for establishment of effective preemptive analgesia are the 
establishment of an effective level of antinociception before injury, and the 
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continuation of this effective analgesic level well into the post- injury period to 
prevent central sensitization during the inflammatory phase (30).  
 
The idea of preemptive analgesia is attractive, especially true when the management 
of postoperative pain has been criticized over the last 30 years, despite the advent of 
increasingly high-technology approaches. If preemptive analgesia worked, 
improvement in patient comfort, decrease in postoperative morbidity and potential 
healthcare saving could be anticipated (21, 30). 
 
1.4 Cyclooxygenase inhibitors  
The cyclooxygenase (COX) enzyme catalyses the first step in the conversion of 
arachidonic acid to prostanoids (prostaglandins and thromboxanes) (Figure 1.2). The 
COX enzyme exists in at least 2 distinct isoforms; a largely constitutive form termed 
COX-1, which plays a role in platelet aggregation, homeostasis, and the protection of 
gastric mucosa; and a largely inducible isoform termed COX-2, which is a crucial 
mediator of pain, inflammation, and fever (16, 31).  
 
Cyclooxygenase inhibitors, both selective and non-selective inhibitors, act by 
inhibiting prostaglandin synthesis. Prostaglandin (PG) is the primary noxious 
mediator released from injured tissues which is responsible for activation of primary 
afferents and sensitization of nociceptors to secondary and tertiary mediators 
(substance P, bradykinin, and histamine). Both forms of COX regulate the synthesis 
of PG in general. However, PG synthesized by COX-2 activity (primarily PGE2) 
mediates a pain response that includes inflammation; the specific interruption of the 
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COX-2 pathway disrupts this process, and thus the primary noxious mediator can be 
blocked and the action of second- and third-order downstream mediators may be 
reduced (16). Moreover, the expression of COX-2 enzyme in the dorsal horn neurons, 
induced by inflammation and nerve injury, is believed to contribute to neuronal 
plasticity and central sensitization. This suggests that cyclooxygenase inhibitors 







Figure 1.2 Cyclooxygenase pathways and mechanism of action of coxibs and 
NSAIDs. COX-1, a constitutive enzyme, plays a major role in the release of PG to 
protect gastric mucosa and regulate homeostasis. COX-2, an inducible enzyme, 
releases PG that mediates pain, inflammation, and fever. Nonselective NSAIDs 
inhibit both forms of COX, while coxibs selectively inhibit COX-2, resulting in 
control of pain and inflammation with a minimal effect on bleeding and gastric 
mucosa (16). 
 
Coxibs    
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1.4.1 NSAIDs or non-selective COX inhibitors  
Non-selective NSAIDs inhibit both isoforms of COX enzyme. The inhibition of 
COX-2 activity has more direct implication in ameliorating inflammation, whereas, 
the inhibition of COX-1 enzyme has been related to adverse effects commonly seen in 
NSAIDs. The major side-effects of NSAIDs treatment are well documented and 
include gastrointestinal toxicity (such as perforation and bleeding), impaired 
homeostasis, and depression of renal function. However, it is suggested that the 
incidence of such side-effects is very low in the context of short-term postoperative 
pain treatment (34-37). 
 
NSAIDs have been widely used in postoperative pain management as single-or 
multimodal-regimen. It has been proven to be reliable for relieving postoperative pain 
after minor procedures, such as, dental surgery and episiotomy (38). When given 
concurrently with opioids, NSAIDs have reduced postoperative opioid consumption 
by 17-40% and patients have benefited from an earlier return of postoperative bowel 
function and a lower incidence of bladder spasm (34, 39). 
 
1.4.2 Selective COX-2 inhibitors (coxibs) 
Specific inhibitors of COX-2 or the selective COX-2 inhibitors (coxibs) were 
developed with the aim of maintaining analgesic and anti- inflammatory efficacies that 
is similar to traditional, non-selective NSAIDs, but avoiding the gastrointestinal 
complications associated with the inhibition of COX-1 enzymes (Figure 1.2) (17, 40, 41). 
At physiological doses, the coxibs selectively inhibit only COX-2, thus minimizing 
the adverse effects mediated through inhibition of COX-1 (42). Currently available 
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clinical data suggested that the coxibs demonstrated clinical efficacy equivalent to 
that of NSAIDs in the treatment of pain and inflammation, while keeping the gastric 
and coagulation side-effects to a minimum (33, 34, 43, 44). Nevertheless, coxibs do not 
offer a clinically relevant advantage over the non-selective group with regards to the 
renal adverse effect and concerns over the cardiovascular risk of coxibs have been 
raised recently (43, 45). 
 
1.5 Tramadol 
Tramadol hydrochloride is a centrally acting, synthetic analgesic with two distinct, 
but complementary, mechanisms of action: a weak opioid agonist with selective 
affinity at the µ- opioid receptors; and a weak inhibitor of the reuptake of 
noradrenaline (norepinephrine) and serotonin (46). Its main advantages over 
conventional opioids – sparseness of opioid-related side effects such as respiratory 
depression, constipation, tolerance and dependence, has made it a favorable choice for 
postoperative pain, refractory cancer pain, chronic inflammatory disorder and 
neuropathic pain (47). 
 
1.6 Animal models of pain 
Animal models play a critical role in the understanding of human pain. Several animal 
models had been introduced to replicate painful clinical condition with which to 
examine pathogenic mechanisms and explore therapeutic options, e.g. hot plate test, 
tail flick test, formalin test et cetera. However, the utility of the knowledge derived 
from these studies is fully dependent on a close match of the model to human disease 
(48). It has been suggested that neither pain caused by chemical irritation nor 
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neuropathic pain models operate on a time scale that parallels the clinical operative 
and postoperative states. Furthermore, pain from a surgical incision is usually 
occurring at rest and is exacerbated by coughing, ambulation, and mechanical 
stimulation, thus mechanical sensitivity is an important property of a surgical incision. 
It is therefore suggested that the efficacy of postoperative analgesic treatments should 
be assessed using evoked responses during function if outcome is to improve with 
enhanced analgesia (49, 50). 
 
In order to advance the knowledge of postoperative pain and gain a better 
understanding of the mechanisms of pain from an incision, a new model of 
postoperative pain involving rats was introduced in 1996 by Brennan et al., and 
validated pharmacologically by Zahn et al., (49, 51, 52). This model demonstrated 
reproducible and quantifiable mechanical hyperalgesia, which can last for several 
days after the incision. It was reported that the duration of mechanical hyperalgesia in 
this model is similar to the period of mechanical sensitivity and evoked pain from 
coughing observed postoperatively in humans. This animal model of incisional pain 
should allow understanding in mechanisms of sensitization caused by surgery and 
facilitate investigation of novel therapies for postoperative pain in humans (49). 
 
1.7 Complementary and Alternative Medicine (CAM)  
Traditional, complementary and alternative medicines (CAM) are becoming 
increasingly popular with more frequent use throughout the world and gaining 
acceptance in the healthcare system (53). The World Health Organization (WHO) 
Traditional Medicines Strategy 2002-2005 (54) has therefore, reviewed the status of 
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Traditional Medicine (TM)/ Complementary and Alternative Medicine (CAM) 
globally; and defined its role in TM/CAM by developing a strategy to address issues 
of policy, safety, efficacy, quality, access and rational use of traditional, 
complementary and alternative medicines. According to the report, the use of TM 
remains widespread in developing countries, while the use of CAM is increasing 
rapidly in developed countries. In Malaysia, a developing country, traditional forms of 
Malay, Chinese and Indian medicines are used extensively; it is estimated that, 
US$500 million is spent annually on TM/CAM compared to about US$300 million on 
allopathic medicine (54). On the other hand, the percentage of the population, which 
used CAM at least once, is 75% in France, 70% in Canada, 48% in Australia and 42% 
in United States (54). 
 
WHO defines Traditional Medicine as “including diverse health practices, approaches, 
knowledge and beliefs incorporating plant, animal, and/or mineral based medicines, 
spiritual therapies, manual techniques and exercises applied singularly or in 
combination to maintain well-being, as well as to treat, diagnose or prevent illness.” 
This definition encompasses the various commonly used Traditional Chinese 
Medicine (TCM) therapies, for example, Chinese herbal medicines (CHM) and 
acupuncture. TCM can be considered the most common form of unconventional 
treatment, especially among the majority ethnic Chinese in Singapore. The use of 
TCM has become part of local lifestyle as it is common practice to incorporate 
Chinese Medicinal Materials (CMM) into daily meals or beverages, for example 
soups, herbal tonic or herbal tea to build up body resistance to disease, to restore 
health during convalescence or to raise energy levels. 
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In a study carried out in 1994 by the Ministry of Health, Singapore (MOH) (55), about 
45% of Singaporeans had consulted a TCM practitioner in the past, with the highest 
proportion among the Chinese (54%), and a much smaller proportion of Malays (8%) 
and Indians (16%).  About 12% or 10,000 of daily outpatient attendance were 
estimated to be seen by TCM practitioners. The Traditional Chinese Medicine 
Practitioner’s Act (TCMP Act) was passed in November 2000 by the Singapore 
Parliament. The Act requires TCM practitioners who practise the prescribed practice 
of TCM to be registered and issued with a license to practise. As at June 2003, a total 
of 1701 were registered as TCM practitioners and/or acupuncturists under the 
Register of TCM practitioners, as compared to 6231 western physicians who 
registered with the Singapore Medical Council (56). From these figures, it appears that 
TCM is an established alternative medicine in Singapore.  
 
1.7.1 The role of CAM in pain management 
Several studies have engaged in analyzing the use of CAM therapies alone or in 
conjunction with conventional therapy in pain complaints. The prevalence of CAM 
used in pain management varies from 5.9% to 40.3% in different settings (3, 57-59). 
Although patients’ satisfaction varies from study to study, CAM seems to be a 
frequent option for many patients (60). It was found that acupuncture, massage and 
herbal remedies were the more popular treatments used. In the Singapore setting, 
study carried out by MOH (55) found that out of a total of 2530 respondents, 30% 
consulted a TCM practitioner for sprains and 18% for aches and pains. Hence, pain 
problems appear to be commonly presented to TCM practitioners in Singapore. 
 




TCM refers to raw herbs, ready-made herbal products for oral consumption or 
external use, acupuncture and Chinese massage therapy used in the system of 
therapeutics according to traditional Chinese method. Ready-made products refer to 
patent herbal products either for oral consumption or external use, and medicated 
plasters with herbal ingredients.  
 
Conventional medicine  is a medical science that is rooted in Greek philosophy. It is 
considered by many as mainstream medicine, Western medicine or modern medicine. 
It is the basis of Singapore’s primary and secondary health care system. Practitioners 
of this branch of medicine are called conventional doctors. They are trained in the 
universities, medical schools and hospitals where they are taught clinical medicine, 
basic medical sciences and clinical skills. 
CMM (55) can be grouped into the following 2 categories: 
1. Raw CMM are substances which are used in their natural states. They may have 
been subjected to simple processing like cutting and drying. 
2. Chinese proprietary medicines (CPM) are CMM that have been formulated into 
finished products in the form of tablets, pills, mixtures, et cetera. They contain only 
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1.8 Aims of study 
Pain is a very common complaint presented by patients, and it represents a major 
primary healthcare problem which is worthy of more attention. Hence, the focus of 
our research is on pain management from two perspectives:  
(1) Assessment of “preemptive analgesia” for postoperative pain in an animal model 
and a pilot clinical study,  
(2) Survey of the use of Traditional Chinese Medicine (TCM) for ambulatory acute or 
chronic pain management in Singapore. 
 
An animal experimental study in rats was designed to compare the preemptive 
analgesic properties of three different classes of analgesics, namely NSAIDs, COX-2 
inhibitors and tramadol. Five different drugs were chosen in this study, celecoxib, 
etoricoxib, indomethacin, naproxen and tramadol. The second clinical study looked 
into the analgesic efficacy of preoperatively administered rofecoxib and tramadol in 
haemorrhoidectomy patient s. The third questionnaire survey investigated the 
prevalence of and common reasons for the use of TCM to treat pain problem and 
patient perceptions on the use of conventional analgesics and/or TCM for pain. 
 
 
                                                                                                Chapter II – Animal study 
 16 
 
Chapter II – Animal study: The preemptive analgesic effect of 
celecoxib, etoricoxib, indomethacin, naproxen and tramadol 
 
2.1 Hypothesis  
The role of oral NSAIDs, coxibs and tramadol in preemptive analgesia has not been 
extensively studied, especially in the rat model of incisional pain. We hypothesized 
that by utilizing a more appropriate animal model of incisional pain, the preemptive 
analgesic effect of celecoxib, etoricoxib, indomethacin, naproxen and tramadol would 
be better demonstrated. This animal study was designed to evaluate the preemptive 
analgesic effects of five drugs, celecoxib, etoricoxib, indomethacin, naproxen and 
tramadol, in the rats’ model of incisional pain. In addition, the time-effectiveness and 
dose-effectiveness investigation of etoricoxib when administered preoperatively at 
different times or different doses were also carried out. 
 
2.2 Materials and Methods  
The experimental protocols were reviewed and approved by the Laboratory Animals 
Center, National University of Singapore. The animals were treated in accordance 
with the Ethical Guidelines for Investigations of Experimental Pain in conscious 
animals as issued by the International Association for the Study of Pain (61). 
Experiments were performed on adult male Sprague-Dawley rats (weight 250-300g). 
Before the surgery, animals were housed in pairs with free access to food and water. 
Postoperatively, the animals were housed individually and the incision was checked 
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daily; any sign of wound infection or dehiscence excluded the animal from the study. 
All animals were euthanised at the end of the protocol. 
 
2.2.1 Surgery 
Skin incision surgery was performed as previously described by Brennan et al., 
(Figure 2.1) (49, 52) with minor modification. All rats were anaesthetized with a mixture 
of fentanyl/fluanisone and midazolam (2.7ml/kg i.p.) and the plantar surface of the 
left hind paw was prepared in a sterile manner with 10% v/v povidone- iodine solution. 
A 1-cm longitudinal incision was made with a number-11 blade, through skin and 
fascia of the plantar aspect of the foot, starting 0.5 cm from the proximal edge of the 
heel and extending toward the toes. The plantaris muscle was elevated and incised 
longitudinally. Following homeostasis with gentle pressure, the skin was opposed 
with two single interrupted sutures using 5-0 mersilk sutures. The wound site was 
covered with gentamycin antibiotic cream and the animals were allowed to recover 
individually in a cage. 
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Figure 2.1 Different stages of the 
surgery procedures carried out on 
the rat foot (49).  
 
A: a 1-cm longitudinal incision is 
made through the skin and fascia 
starting 0.5 cm from the proximal 
edge of the heel and extending 
toward the middle of the foot.  
 
B: the plantaris muscle is elevated 
and also incised longitudinally.  
 
C: after hemostasis, the wound is 
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2.2.2 Postoperative testing 
Withdrawal responses to mechanical stimulation. Mechanical allodynia was measured 
with an automated dynamic plantar Von Frey apparatus (Dynamic Plantar 
Aesthesiometer, UgoBasil, Italy. Figure 2.2). The rats were placed individually on an 
elevated framed metal mesh floor covered with two-compartment plastic enclosure. 
Following acclimation, a stainless steel filament of 0.5 mm diameter was 
electronically delivered to the plantar hindpaw from underneath the cage to an area 
adjacent to the wound and to the same area on the non- injured foot. The filament was 
pushed against the hindpaw with ascending force, ramping from 0-50 gram over a 10-
second period. When the animal responded to the stimulus by withdrawing its 
hindpaw, the mechanical stimulus was automatically withdrawn and the force at 
which the animal responded was recorded. The cut-off value, 50 g, was recorded even 
if there was no withdrawal response to this force. Measurements were repeated twice 
with a 3-5 min test- free period between each trial. The withdrawal threshold was 
determined by the average of these 3 measurements. The animals were tested before 
surgery (Baseline), at 4 hr after surgery (4 hr Day 0), and once daily for 3 days 
postoperatively (Day 1, Day 2 and Day 3). 
 
Pain score. A numerical pain scoring system was developed to further assess the pain 
behavior (Appendix I). The scale was developed by adapting from several measures 
that had been used in other studies (62-64), which was then customized to fit our 
protocol. The observation parameters include the appearance (general grooming, 
eyelid closure, ocular/nasal discharge), behavioral changes (biting/licking of the 
 
                                                                                                Chapter II – Animal study 
 20 
wound, vocalization, overall activity, provoked activity), clinical sign 
(diarrhea/abnormal discharge), body weight changes and weight bearing score (49). 
The observation was done when the unrestrained animals were placed on an elevated 
enclosure as described above, 4 hr after surgery and once daily for 3 days 
postoperatively. The cumulative pain score (0-25) provides an indication of the 
overall well-being of the animal. The higher the score, the more likely it is that the 
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2.2.3 Experimental groups  
The experiment was divided into three phases. In phase one, preemptive analgesic 
effects of 5 drugs, celecoxib (30 mg/kg), etoricoxib (30 mg/kg), indomethacin (30 
mg/kg), naproxen (30 mg/kg) and tramadol hydrochloride (40 mg/kg) were evaluated. 
These doses were selected from those used in other studies (65-68). Animals were 
allocated randomly to different drug groups with 5-6 animals per group. The drugs 
were suspended in carboxymethyl cellulose (CMC) 0.5% w/v solution and 
administered orally by gastric gavage in a volume of 1 to 1.5 ml. The control group 
received a placebo 1 hr before and 2 hrs after surgical incision; the preoperative group 
received the active drug 1 hr before and placebo 2 hr after surgery; whereas the 
postoperative group received placebo 1 hr before and active drug 2 hr after surgery.  
Phase two involves a time-effectiveness testing where etoricoxib (30 mg/kg) was 
administered at different time-points preoperatively (1 hr, 12 hr, 1 day [2 doses: 24 hr 
and 1 hr before] and 2 days [3 doses: 48 hr, 24 hr and 1 hr before]). In phase three, the 
dose-effectiveness testing, different doses of etoricoxib (10, 20 and 30 mg/kg) were 
administered 1 hr pre-operatively. 
 
2.2.4 Statistical analysis 
Statistical software SPSS 11.0 for windows was employed in all statistical tests. Data 
analysis was performed using the untransformed data of withdrawal threshold and 
cumulative pain score. Data were analyzed by analysis of variance (ANOVA) 
followed by post hoc Bonferroni correction analysis. In any situation, P = 0.05 is 
considered statistically significant. 
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2.3 Results 
2.3.1 Preemptive analgesic effect between different drugs 
Figure 2.3A- 2.3E compares the withdrawal responses of the five different drugs to 
mechanical stimuli generated by the von frey apparatus, namely celecoxib 30 mg/kg, 
30 etoricoxib mg/kg, indomethacin 30 mg/kg, naproxen 30 mg/kg and tramadol 40 
mg/kg, given before and after operation, respectively. As can be seen from the data 
obtained, the incision of the plantar surface of the hind paw produced a significant 
reduction in the withdrawal threshold, with the lowest point located at 4 hrs after 
operation (4 hr Day 0) and gradually recovering towards the pre- incision baseline 
value. Before the surgery, the rats exhibited baseline withdrawal thresholds which 
ranged from 45.95 ± 3.01 to 48.95 ± 0.95. Similar results were obtained when 
applying the filaments against the plantar aspect of the non-operated hind paw. The 
tested drugs reduced, but did not abolish the post- incisional mechanical allodynia. In 
each experimental group, the withdrawal threshold of animals treated 1 hr before 
operation was significantly higher than that of the control group at all observation 
time-points (except celecoxib at Day 2, and naproxen at Day 3). The effects of 
tramadol given preoperatively were significantly higher than that of the postoperative 
group at four observation points; whereas those given indomethacin and naproxen 
showed differences up to 2 days after surgery; and those on  etoricoxib showed 
differences at Days 1 and 2 after the procedure. On the other hand, no significant 
difference was found between the threshold of the control group and postoperatively-
treated group with the exception of indomethacin at Day 2. 
 



































 Celecoxib 1 hr before op
 Celecoxib 2 hrs after op
 
 
Figure 2.3A Effects of celecoxib (30mg/kg), given 1 hr before operation and 2 hrs 
after operation, on the paw withdrawal threshold in response to mechanical stimuli in 
rats. The withdrawal threshold of animals treated 1 hr before operation was 
significantly higher than that of the control group at all observation time points except 
at Day 2 (P = 0.032, 0.003, 0.004 for 4 hr Day 0, Day 1 and Day 3 respectively). 
Significant difference was found between the before and after operation group at Day 
1 with P = 0.009. No significant difference was found between groups at Day 2. 
 
* P < 0.05 for before operation vs. all groups 
# P < 0.05 for control vs. before operation 
The forces are in grams and expressed as means ± SD.
 




































 Etoricoxib 1 hr before op
 Etoricoxib 2 hrs after op
 
 
Figure 2.3B Effects of etoricoxib (30mg/kg), given 1 hr before operation and 2 hrs 
after operation, on the paw withdrawal threshold in response to mechanical stimuli in 
rats. The withdrawal threshold of animals treated 1 hr before operation was 
significantly higher than that of the control group at all observation time points (P = 
0.004, 0.001, 0.002 and 0.006 respectively). Significant difference was found between 
the before and after operation group at Day 1 and Day 2 with P = 0.001 and 0.016 
respectively.  
 
* P < 0.05 for before operation vs. all groups 
# P < 0.05 for control vs. before operation 
 





































 Indomethacin 1 hr before op
 Indomethacin 2 hrs after op
 
 
Figure 2.3C Effects of indomethacin (30mg/kg), given 1 hr before operation and 2 
hrs after operation, on the paw withdrawal threshold in response to mechanical stimuli 
in rats. The withdrawal threshold of animals treated 1 hr before operation was 
significantly higher than that of the control group at all observation time points (P = 
0.001 for 4 hr Day 0, Day 1 and Day 2, and P = 0.05 for Day 3). Significant 
difference was found between the before and after operation group at 4 hr Day, Day 1 
and Day 2 with P = 0.007, 0.043 and 0.009 respectively. Besides, significant 
difference was also found between the control and postoperation group at Day 2 with 
P = 0.016. 
 
* P < 0.05 for before operation vs. all groups 
# P < 0.05 for control vs. before operation 
+ P < 0.05 for control vs. after operation 
 


































 Naproxen 1 hr before op
 Naproxen 2 hrs after op
 
 
Figure 2.3D Effects of naproxen (30mg/kg), given 1 hr before operation and 2 hrs 
after operation, on the paw withdrawal threshold in response to mechanical stimuli in 
rats. The withdrawal threshold of animals treated 1 hr before operation was 
significantly higher than that of the control group at all observation time points except 
at Day 3 (P = 0.001 for 4 hr Day 0, Day1 and Day2). Significant difference was found 
between the before and after operation group at 4 hr Day, Day 1 and Day 2 with P = 
0.007, 0.014 and 0.001 respectively. No significant difference was found between 
groups at Day 3. 
 
* P < 0.05 for before operation vs. all groups 
 



































 Tramadol 1 hr before op
 Tramadol 2 hrs after op
 
 
Figure 2.3E Effects of tramadol (40mg/kg), given 1 hr before operation and 2 hrs 
after operation, on the paw withdrawal threshold in response to mechanical stimuli in 
rats. The withdrawal threshold of animals treated 1 hr before operation was 
significantly higher than that of the control group at all observation time points (P = 
0.001 for 4 hr Day 0 and Day1, P =0.007 for Day 2 and P = 0.014 for Day 3). 
Significant difference was found between the before and after operation group at all 
observation time points with P = 0.001, 0.024, 0.005 and 0.012 respectively.  
 
* P < 0.05 for before operation vs. all groups 
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The results from Figure 2.3A- 2.3E  were then re-organized, according to the time of 
drug administered into preoperative group and postoperative group, with the control 
group remaining unchanged as shown in Figure 2.4A and B. Etoricoxib and tramadol, 
administered 1 hr before incision, produced responses that are significantly different 
from the  control group at all time-points. Although the differences are not statistically 
significant, etoricoxib exhibited a slight edge over all the tested drugs as shown in the 
figures. However, this superiority was not found when the drugs were administered 2 
hrs after incision as shown in Figure 2.4B. 
 
When the five drugs were re-classified into three pharmacological classes, cox-2 
inhibitors (coxibs), non-steroid anti- inflammatory drug (NSAID) and tramadol, 
differences were noted between the control group and each of the classes. No 
superiority among the classes was observed (Figure 2.5). 
 










































Figure 2.4A Effects of preoperative administration of five different drugs on the paw 
withdrawal threshold in response to mechanical stimuli in rats. Celecoxib (30mg/kg), 
etoricoxib (30mg/kg), indomethacin (30mg/kg), naproxen (30mg/kg) and tramadol 
(40mg/kg) were administered to respective animals 1 hr before incision. At 4 hr Day 0, 
significant differences were found between the control group and etoricoxib (P = 
0.001), indomethacin (P =0.031), naproxen (P = 0.008) and tramadol group (P = 
0.005) and between celecoxib and etoricoxib (P = 0.049). Significant differences were 
found between the control and all other groups at Day 1, with P = 0.026, 0.001, 0.001, 
0.023 and 0.005 for celecoxib, etoricoxib, indomethacin, naproxen and tramadol 
respectively. At Day 2, significant differences were found between the control and 
etoricoxib (P = 0.005) and indomethacin group (P = 0.006). At Day 3, significant 
differences were found between the control group and celecoxib (P = 0.028), 
etoricoxib (P = 0.005) and tramadol group (P = 0.047). 
 
* P < 0.05 for control vs. etoricoxib, indomethacin, naproxen and tramadol; and 
Etoricoxib vs. Celecoxib 
f P < 0.05 for control vs. all groups 
# P < 0.05 for control vs. etoricoxib, indomethacin, naproxen and tramadol 
+ P < 0.05 for control vs. celecoxib, etoricoxib and tramadol 
 








































Figure 2.4B Effects of postoperative administration of five different drugs on the paw 
withdrawal threshold in response to mechanical stimuli in rats. Celecoxib (30mg/kg), 
etoricoxib (30mg/kg), indomethacin (30mg/kg), naproxen (30mg/kg) and tramadol 
(40mg/kg) were administered to respective animals 2 hrs after incision. Significant 
differences were found at 4 hr Day1 between the control and etoricoxib group (P = 
0.004), and between the etoricoxib and tramadol group (P = 0.05). 
 
*P < 0.05 for Etoricoxib vs. control and Tramadol 
 









































Figure 2.5 Effects of drug classes (coxibs, NSAID and Tramadol), when given 
preoperatively, on the paw withdrawal threshold in response to mechanical stimuli in 
rats. The withdrawal threshold produced by both coxibs and tramadol was 
significantly higher than that of the control group at all observation time points (P = 
0.006, 0.001, 0.007 and 0.001 for control vs. coxibs at 4 hr Day 0, Day 1, Day 2 and 
Day 3 respectively; and P = 0.007, 0.003, 0.036 and 0.016 for tramadol ). Significant 
difference was found between control and NSAID group at all observation time points 
except Day 3 (P = 0.005, 0.001 and 0.002 for 4 hr Day 0, Day 1 and Day 2 
respectively). Significant difference was also found between the coxibs and NSAID 
group at Day 3 only (P = 0.022). 
 
* P < 0.05 for control vs. all groups 
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Figure 2.6A- 2.6E shows the cumulative pain scores of the rats administered the 
respective drugs over a time course of 3 days after the operation. The highest pain 
score was found at 4 hr after the operation, and decreased over the rest of the 
observation period. The comparisons between control, pre- and postoperative groups 
are shown in the figures. Throughout the experimental period, most of the animals 
remained well groomed and appeared to maintain normal body weight; gait appeared 
unaffected except for impaired weight bearing on the area of the incision on the first 
two days after surgery. However, those receiving indomethacin, both pre- and 
postoperatively, were suffering from mild diarrhea which persisted till Day 3. This 
might have been due to the gastrointestinal side-effect of conventional non-selective 
NSAIDs which caused about 5-10% decrease in body weight, which is reflected by 
higher cumulative pain score on Day 3. 
 



































 Celecoxib 1 hr before op
 Celecoxib 2 hrs after op
 
Figure 2.6A Cumulative pain scores of celecoxib (30mg/kg) given 1 hr before 
operation and 2 hrs after operation. The cumulative pain score for the 1 hr before 
operation group was significantly lower than that of the control group at Day 1 (P = 
0.021) and Day 3 (P = 0.001). Significant difference was found between the control 
and after operation group at Day 3 with P = 0.001. No significant difference was 
found between preoperation and postoperation group. 
 
# P < 0.05 for control vs. before operation 
+ P < 0.05 for control vs. all groups 
 


































 Etoricoxib 1 hr before op
 Etoricoxib 2 hrs after op
 
 
Figure 2.6B Cumulative pain scores of etoricoxib (30mg/kg) given 1 hr before 
operation and 2 hrs after operation. The cumulative pain score for the 1 hr before 
operation group was significantly lower than that of the control group at Day 1 (P = 
0.003) and Day 3 (P = 0.042). Significant difference was found between the before 
and after operation group at Day 1 with P = 0.013. No significant difference was 
found between groups at 4 hr Day 0 and at Day 2. 
 
* P < 0.05 for before operation vs. all groups 
# P < 0.05 for control vs. before operation 
 

































 Indomethacin 1 hr before op
 Indomethacin 2 hrs after op
 
 
Figure 2.6C Cumulative pain scores of indomethacin (30mg/kg) given 1 hr before 
operation and 2 hrs after operation. The cumulative pain score for the 1 hr before 
operation group was significantly lower than that of the control group at Day 1 (P = 
0.001). Significant difference was found between the before and after operation group 
at Day 1 with P = 0.001. No significant difference was found between groups at other 
observation time point. 
 
* P < 0.05 for before operation vs. all groups 
 



































 Naproxen 1 hr before op
 Naproxen 2 hrs after op
 
 
Figure 2.6D Cumulative pain scores of naproxen (30mg/kg) given 1 hr before 
operation and 2 hrs after operation. The cumulative pain score for the 1 hr before 
operation group was significantly lower than that of the control group at Day 1, Day 2 
and Day 3 (P = 0.005, 0.001 and 0.001 respectively). Significant difference was found 
between the before and after operation group at Day 1 with P = 0.001 and Day 2 with 
P = 0.016. Significant difference was also found between the control and after 
operation group at Day 3 (P = 0.001). 
 
* P < 0.05 for before operation vs. all groups 
+ P < 0.05 for control vs. all groups 
 

































 Tramadol 1 hr before op
 Tramadol 2 hrs after op
 
 
Figure 2.6E Cumulative pain scores of tramadol (40mg/kg) given 1 hr before 
operation and 2 hrs after operation. The cumulative pain score for the 1 hr before 
operation group was significantly lower than that of the control group at Day 3 with 
P= 0.001. No significant difference was found between groups at any other 
observation time point. 
 
 # P < 0.05 for control vs. before operation 
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2.3.2 Effects of time and dose of administration 
Figure 2.7 summarizes the time effectiveness of 30 mg/kg etoricoxib, administered at 
different time-points before the operation (1 hr, 12 hrs, 1 day and 2 days before 
operation). None of the group exhibited superiority. Differences were only found 
between the control group and the 1 hr or 12 hrs groups. When the drug was given 1 
hr before incision, the threshold was significantly higher than that of control group at 
all time-points. When it was given 12 hrs before incision, the threshold was 
significantly higher than that of control group at Days 1, 2 and 3. 
 
Figure 2.8 shows the withdrawal thresholds of different doses of etoricoxib (10, 20 
and 30 mg/kg) when given 1 hr before the operation. These three groups showed no 
statistical significant difference. However, when compared with the control group, the 
thresholds of 20 mg/kg and 30 mg/kg groups showed a similar trend and are 
significantly different from that of control group (except 30 mg/kg at Day 2). The 
withdrawal thresho ld of animals treated with etoricoxib 30mg/kg was significantly 
higher than that of the control group at all observation time points except at Day 2 (P 
= 0.004, 0.005, 0.008 for 4 hr Day 0, Day 1 and Day 3, respectively). The withdrawal 
threshold of animals treated with etoricoxib 20mg/kg was significantly higher than 
that of the control group at all observation time points (P = 0.034, 0.003, 0.044, 0.049 
for 4 hr Day 0, Day 1, Day 2 and Day 3, respectively).  
 




































 1 hr before op
 12 hrs before op
 1 day before op




Figure 2.7 Withdrawal thresholds when 30 mg/kg etoricoxib was given at different 
time points preoperatively. The withdrawal threshold of animals treated 1 hr before 
operation was significantly higher than that of the control group at all observation 
time points (P = 0.006, 0.002, 0.003 and 0.035 for 4 hr Day 0, Day 1, Day 2 and Day 
3 respectively). Significant difference was found between the control and 12 hrs 
before operation group at Day 1 (P = 0.015), Day 2 (P = 0.001) and Day 3 (P = 0.033). 
At Day 2, significant difference was also found between the control and 1 day before 
operation group, P = 0.014; between the 12 hrs and 1 day before operation group, P = 
0.028; and between the 12 hrs and 2 days before operation group, P = 0.001. 
 
* P < 0.05 for control vs. 1 hr group 
f P < 0.05 for control vs. 12 hr and 1 hr group 
# P < 0.05 for control vs. 12 hr, 1 hr, 1 Day group; and for 12 hr vs. 1 Day and 2 
Days group.
 



































 Etoricoxib 30 mg/kg
 Etoricoxib 20 mg/kg
 Etoricoxib 10 mg/kg
 
 
Figure 2.8 Withdrawal thresholds when different doses of etoricoxib (30mg/kg, 
20mg/kg and 10mg/kg) were given 1 hr before surgery. The withdrawal threshold of 
animals treated with etoricoxib 30mg/kg was significantly higher than that of the 
control group at all observation time points except at Day 2 (P = 0.004, 0.005, 0.008 
for 4 hr Day 0, Day 1 and Day 3 respectively). The withdrawal threshold of animals 
treated with etoricoxib 20mg/kg was significantly higher than that of the control 
group at all observation time points (P = 0.034, 0.003, 0.044, 0.049 for 4 hr Day 0, 
Day 1, Day 2 and Day 3 respectively).Significant difference was found between the 
control and etoricoxib 10mg/kg group at 4 hr Day 0 (P = 0.045) and Day 1(P = 0.026).  
No significant difference was found between different doses group at any observation 
time point. 
 
* P<0.05 for control vs. all groups 
# P<0.05 for control vs. 20 mg/kg group 
+ P<0.05 for control vs. 30 mg/kg and 20mg/kg group. 
 
 




In this study, the preemptive analgesic effects of celecoxib, etoricoxib, indomethacin, 
naproxen and tramadol were evaluated in a rat model of incisional pain. It was done 
by comparing the withdrawal thresholds and cumulative pain scores between the 
groups, namely, the control, preoperative and postoperative groups which were 
administered with different drugs. 
 
The findings indicate that, preoperative administrations of the five drugs exhibited 
significantly higher withdrawal thresholds than that of placebo control group for 3 
days after surgery. Preoperative administration of etoricoxib, indomethacin, naproxen 
and tramadol produced an effect which was significantly higher when compared with 
that of postoperative administration for up to 2 days after the surgery (please refer to 
respective figures for P value). These findings suggest that the four drugs exhibit 
better analgesic effect when given preoperatively, which supports the idea of 
preemptive analgesia. Taking tramadol as a typical example, Figure 2.3E shows that 
preoperative administration of tramadol exhibited a significant difference in 
withdrawal threshold when compared with both postoperative tramadol and the 
control group at all observation time-points. The withdrawal threshold of animals 
treated 1 hr preoperatively was significantly higher than that of the control group at all 
observation time points (P = 0.001 for 4 hr Day 0 and Day1, P =0.007 for Day 2 and 
P = 0.014 for Day 3). Significant difference was found between the before and after 
operation group at all observation time points with P = 0.001, 0.024, 0.005 and 0.012, 
respectively. Moreover, no significant difference was found between the responses in 
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the postoperative and control groups. These may suggest that tramadol exerts better 
analgesic effect when administered preoperatively than postoperatively. This finding, 
however, has not been fully supported by clinical studies focused on preemptive 
analgesic effect of tramadol, and the published results are conflicting (69-71). 
 
Whiteside et al., (65) had reported in their study that the antinociceptive effects of 
several analgesics are dose-dependent with the greatest effects being observed at the 
highest doses. In our study, although the dose-dependent property is not obvious, 
however an adequate dose was needed in order to obtain good preemptive analgesic 
effect. At the lower dose, etoricoxib 10 mg/kg in our case, showed an improvement 
over the control group, the difference is not significant. There is a risk of masking of 
the preemptive analgesic properties of a potential drug if sub-optimal dose is used. 
The doses of drugs used in this study were selected from those used in other studies 
(65-68), but none of them had been applied for evaluation of the preemptive analgesic 
effects in this model. Celecoxib 30 mg/kg in our study yielded a less preemptive 
analgesic effect compared with other drugs. This result should not be interpreted 
absolutely, as further studies should be conducted using higher doses of celecoxib 
before a conclusion can be drawn.  
 
In our study, single-dose regimen was used in both pre- and postoperative settings. It 
is noted that a single dose of drug, when administered 1 hr preoperatively, produced 
an effect that lasted for 2 or 3 days postoperatively. This finding further supports the 
idea of preemptive analgesia which prevents the establishment of central sensitization 
caused by incisional and inflammatory injuries and covers the period of surgery and 
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the initial postoperative period. Further study may involve multi-dosing regimens 
which extend into the recovery period to further control the postoperative pain. 
 
In this study, we compared the withdrawal threshold produced by 30mg/kg etoricoxib 
given at different time points preoperatively (1hr, 12 hrs, 1 day and 2 days before 
operation). According to Figure 2.7, the withdrawal thresholds of animals treated 1 hr 
and 12 hrs before operation were significantly higher than that of the control group at 
all observation time points (except 4 hr Day 0 for 12 hrs before operation group). 
However, these four groups did not show any superiority when compared among each 
other. Significant difference was only found at Day 2 between 12 hrs and 1 day before 
operation group (P = 0.028) and between 12 hrs and 2 days before operation group (P 
= 0.001). No other significant difference in preemptive analgesic effectiveness for 
etoricoxib administered 1 hr, 12 hr, 1 day and 2 days before incision was observed. 
Thus, the timing of drug administration is unlikely to be a prerequisite for preemptive 
analgesia, which is consistent with another study (72). Nevertheless, the basic 
pharmacokinetic parameters such as half- life (t1/2) and time to the maximum 
concentration (tmax) must be taken into consideration when choosing a suitable 
candidate and planning a relevant study. 
 
Pain in animals is difficult to assess. Besides the withdrawal responses to mechanical 
stimuli, a numerical pain scoring scale has been developed in this study to further 
assess the pain status in rats. The scale was developed by adapting from several 
measures that had been used in other studies (62-64), which was then customized to fit 
into our protocol. The results showed that the pain scores of preoperative group are 
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generally lower than that of control group, which is consistent with the result of the 
withdrawal responses. However, when comparing the pain score between pre- and 
postoperative group, the significant difference was only found in four points, at Day 1 
in the etoricoxib group (P = 0.013), at Day 1 in the indomethacin group (P = 0.001), 
at Day 1 and Day 2 in naproxen group (P = 0.001 and 0.016). The result is too minute 
to permit a conclusion. Some limitation has been noted. The scale used here has not 
been validated in any other situation, and in fact there is a general lack of validated 
scales available. The parameter used in this scale depends on the clinical appearance 
of the rats which is always subjective and varies considerably. The signs of pain may 
be very subtle, and some of it may only be noticeable at night. Thus, it strongly 
depends on the experience of the observer who should be familiar with the normal and 
abnormal behaviors of rats. Despite these limitations, it provides a means for close 
observation of animal well-being, any harmful abnormality can be identified and 
decision can then be made to discontinue the protocol and the animal be sacrificed 
accordingly. 
 
Moderate to severe peri-operative pain has traditionally been managed using opioid- 
analgesics, with morphine being the standard reference drug, because of its known 
potency and fast onset of action. However, concerns regarding opioid-related side-
effects (e.g. CNS depression and sedation, respiratory depression, nausea, vomiting, 
urinary retention, constipation, tolerance and the potential for abuse by health care 
professionals) limit the use of opioids despite their analgesic efficacies in 
postoperative analgesia; and have stimulated a search for powerful non-opioid 
analgesics (73, 74). Non-steroidal anti- inflammatory drugs (NSAIDs, e.g. indomethacin 
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and naproxen), cyclooxygenase-2 inhibitors (coxibs, e.g. celecoxib and etoricoxib) 
and tramadol, which act through different pathways, may be used to fill this need. 
Conventional nonselective NSAIDs have well recognized adverse effects (e.g. 
interference in platelet aggregation, homeostasis and irritation of gastric mucosa) that 
are contraindications in the preoperative setting, making coxibs (selective Cox-2 
inhibitors) and tramadol (centrally acting, synthetic opioid analgesia) better choices as 
preemptive analgesia. 
 
The finding of this study is encouraging, and may arouse the interest of further 
research on the preemptive analgesia. Future studies on the combination of 
preemptive analgesia and multimodal analgesic strategy, multi-dose regimen trials 
and randomized controlled clinical trials will be needed to confirm the clinical 
relevance of preemptive analgesia. 
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Chapter III – Clinical study: Analgesic efficacy of tramadol and 
rofecoxib in Asian haemorrhoidectomy patients 
 
3.1 Hypothesis 
Pain control following surgery remains an important aspect of patient care in the 
ambulatory setting and this is true for the postoperative haemorrhoidectomy patient 
(75). Currently, there is no published study comparing the analgesic efficacies of 
tramadol and rofecoxib in patients undergoing haemorrhoidectomy. Rofecoxib, with 
its anti- inflammatory property and longer elimination half- life (12 hrs vs. 6 hrs), may 
make a better analgesic than tramadol when administered preoperatively. We 
hypothesized that rofecoxib administered 1 hr preoperatively would give better pain 
control and side effect profile than that of tramadol. The aim of this study was to 
compare the analgesic efficacies and safety profiles of tramadol and rofecoxib in 
Asian patients undergoing haemorrhoidectomy. 
 
3.2 Materials and Methods  
3.2.1 Clinical setting and subjects 
The study was conducted at Singapore General Hospital (SGH) with approval from 
the hospital’s ethics committee and all participants signed the informed consent forms. 
Patients who were scheduled to undergo haemorrhoidectomy at SGH, who were at 
least 21 years of age, able to take oral medication and able to communicate 
meaningfully, were considered for recruitment in the study. Patients were excluded if 
they had a known hypersensitivity to tramadol or rofecoxib or other NSAIDs, with a 
 
                                                                                              Chapter III – Clinical study 
 47 
history of seizure disorder, epilepsy or other neurological impairment, with suspected  
abuse of narcotics or alcohol, are pregnant or lactating, with impaired renal or liver 
function, are undergoing concurrent treatment with monoamine oxidase inhibitors 
(MAOIs) or analgesic agents, with severe terminal illness, with a his tory of peptic 
ulcer disease, gastrointestinal bleeding or perforation or severe congestive heart 
failure. 
 
This was a single-blind study, only the investigators were aware of which intervention 
each patient is receiving. Patients undergoing haemorrhoidectomy were assigned 
randomly using computer generated random numbers to receive either one of two 
treatments: tramadol hydrochloride (Tramadol 50 Stada®; STADApharm) 100 mg 
preoperatively and subsequently 50 mg three times daily when required for pain, or 
rofecoxib (Vioxx™; MSD) 50 mg preoperatively and subsequently 50 mg once a day 
when required for pain. Preoperative dose was administered no less than 1 hour before 
operation with a measured amount of 20 ml of water. 
 
After surgery, patients were transferred to the recovery area where they were 
monitored by the anesthetists and nurses before being discharged to their respective 
wards. In case of inadequate pain relief at the recovery area, rescue analgesia was 
provided by titrated doses of morphine in accordance with hospital policy. Patients 
were advised to take the study medication as directed when they were discharged 
from the hospital. If the study medication was inadequate for pain relief 1 hour after 
administration, patients were instructed to take oral rescue medication, which was two 
500 mg tablets of paracetamol, up to a maximum of 8 tablets a day. 
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All operations were performed under general anesthesia. The anesthetic regimes were 
standard to the local hospital practice. Induction and maintenance anesthetic agents 
were given at the discretion of the attending anesthetist. 
 
3.2.2 Pain and postoperative measures 
Pain scores were obtained from the patients at the time the preoperation analgesic 
dose was administered, and at 0.5, 1, 1.5, 2, 3, 4 hours after surgery. Pain scores were 
also obtained at time of discharge and daily for 3 days after the day of the surgery 
using telephone contact. Pain assessment was conducted using the Numerical Rating 
Scale (NRS, Appendix II) and Verbal Rating Scale (VRS, Appendix III). The NRS 
consists of a series of numbers ranging from 0 to 10 with end-points being labeled 
with ‘no pain’ and ‘worst possible pain’, respectively. The VRS is a list of adjectives 
describing the different levels of pain intensity on a 5-point scale, which was scored 
as follows: no pain (0); no pain at rest, slight pain on movement (1), slight pain at rest, 
moderate pain on movement (2); moderate pain at rest, severe pain on movement (3), 
severe pain at rest, and on movement (4). Patients were asked to rate their pain 
according to the number or adjectives that best corresponded to their pain. The 
consumption of rescue medication was noted from the patient medication record and 
patient’s recall during the follow-up telephone interview. 
 
Side effects were recorded based on those observed by the investigator or based on 
patient’s responses. Safety of the study medications was evaluated based on the 
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incidence of side effects experienced by the patients in the inpatient setting and after 
discharge. 
 
Both the English versions of the NRS and VRS were translated into Chinese and 
Malay. All interviews and explanation of the protocol were conducted in either 
English, Chinese and Malay language according to patient’s preference. 
 
3.2.3 Statistical analysis 
Computer software SPSS 11.0 for windows was employed in all statistic tests. 
Significance was tested by unpaired two-tailed student’s t test or Fisher’s Exact test 
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3.3 Results 
Twenty-five patients completed the study with 11 patients in the tramadol group and 
14 in the rofecoxib group. Demographic data concerning the patient’s age, gender, 
race, method of haemorrhoidectomy and baseline (preoperative) pain scores were 
shown in Table 3.1. There were no significant differences between two treatment 




Table 3.1 Demographic Data, by treatment group. 
Variable  Tramadol (n = 11) Rofecoxib (n = 14) 
Age (mean ± SD) 43.18 ± 8.750 36.50 ± 10.733 
Gender (No., %) 
          Male 







Race (No., %) 
          Chinese 







Method of haemorrhoidectomy (No., %) 
          Conventional  







Baseline pain score (NRS, mean ± SD) 0.36 ± 1.206 0.5 ± 1.160 
SD = Standard Deviation, NRS = Numerical Rating Scale 
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The mean NRS and VRS pain scores obtained at 11 assessment time-points over a 4-
day study period were shown in Figure 3.1A and 3.1B. The tramadol group had lower 
NRS pain scores preoperatively and at 0.5, 1 and 4 hours postoperatively, and the 
rofecoxib group had lower pain scores for the rest of the time. The distribution of 
VRS pain scores was similar to that of the NRS; the tramadol group had lower VRS 
pain scores preoperatively and at 0.5 and 1 hour postoperatively, whereas the 
rofecoxib group showed lower pain scores at other assessment points. However, the 
differences between groups were not statistically significant at any of the assessment 
time-points for both NRS and VRS pain scores, with exception at Day 3. 
 
At day 3 after the surgery, 90% of patients described their feelings with either ‘no 
pain’ or ‘no pain at rest, slight pain on movement’. Only one patient (from tramadol 
group and underwent conventional haemorrhoidectomy) described her feeling as 
‘moderate pain at rest, severe pain on movement’ and rated the NRS as 9. This patient 
complained that her wound was swollen and inflamed; she was then referred back to 
hospital.  
 
The number of study medication taken postoperatively was monitored through the 
follow-up telephone interview. Rofecoxib was required by all patients for 3 days 
postoperatively except 1 patient who did not need any analgesic for the second and 
third day postoperatively. Tramadol was required by most of the patients for 3 days 
postoperatively except 2 patients. One of them refused to take any analgesic for pain 
relief even though she still felt some pain after discharge from hospital. This patient 
was then advised to take medication for pain relief according to the prescription. 
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Another patient did not need any analgesic for the third day after operation. There 
were 2 and 4 patients in the tramadol and the rofecoxib groups, respectively, (18.2% 
vs. 28.6%, p > 0.1) who needed rescue medicine because of insufficient pain relief. 
One of the patients in the tramadol group was given pethidine intravenously at the 
recovery unit, and required oral paracetamol later on. The other patient in the 
tramadol group took paracetamol as rescue medicine. Only one patient in the 
rofecoxib group needed extra morphine intravenously as rescue medicine at the 
recovery unit while another three required oral paracetamol at home. One of them 
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Figure 3.1A Time-effect curve for mean Numerical Rating Scale (NRS) pain scores 
for two treatment groups. Significant difference between two treatment groups was 
detected only at Day 3 (P = 0.046). No significant difference was found at any other 
observation time point. 
 
* P < 0.05 
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Figure 3.1B Time-effect curve for mean Verbal Rating Scale (VRS) pain scores for 
two treatment groups. Significant difference between two treatment groups was 
detected only at Day 3 (P = 0.038). No significant difference was found at any other 
observation time point. 
 
* P < 0.05 
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The unwanted symptoms presented or reported by patients postoperatively were 
nausea, nausea with vomiting, dizziness, hypotension, urinary retention, shivering, 
constipation, bloated and diarrhea. The summary of the incidence of symptoms 
presented by patients is shown in Table 3.2. The incidence of nausea and dizziness 
was significantly higher in the tramadol group compared to the rofecoxib group. 
There were no significant differences in other incidences as shown in Table 3.2. 
However, it is noted that the tramadol group showed relatively higher incidence of 
both nausea with vomiting and hypotension compared with the rofecoxib group. More 
that half (54.5%) of the patients who took tramadol preoperatively showed nausea 
with vomiting or hypotension (different patients were involved for each episode). The 
hypotensives needed normal saline infusion to restore their blood pressure at the 
recovery unit and two patients in the tramadol group needed ondansetron 
intravenously to control the symptoms. None of them showed either of the symptoms 
on the first day after surgery. 
 
Table 3.2 Side effects experienced by patients, by treatment group. 
Symptom Tramadol (n = 11) No. (%) 
Rofecoxib (n = 14) 
No. (%) p-value  
Nausea 7 (63.6%) 3 (21.4%) < 0.05 
Nausea with vomiting 6 (54.5%) 2 (14.3%) 0.081 
Dizziness 8 (72.7%) 3 (21.4%) < 0.05 
Hypotension 6 (54.5%) 2 (14.3%) 0.081 
Urinary retention 1 (9.1%) 3 (21.4%) 0.604 
Shivering 2 (18.2%) 1 (7.1%) 0.565 
Constipation 1 (9.1%) 1 (7.1%) 1.000 
Bloated (gas in stomach) 0 2 (14.3%) 0.487 
Diarrhea 0 1 (7.1%) 1.000 
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3.4 Discussion 
Optimal postoperative pain control should be effective and safe. The analgesic used 
should produce minimal side effects, facilitate recovery and be easily managed by 
patients at home (76).  
 
Quantitative assessment of analgesic efficacy is difficult, since pain is inherently 
subjective in nature, with the severity of pain being affected by emotional factors. 
Thus, there are currently no objective measures available for assessing pain intensity 
(46). In the absence of any truly objective measures, the Verbal Rating Scale (VRS) 
and Numerical Rating Scale (NRS) have been used effectively in hospital clinics and 
have provided valuable information about pain and analgesia. In addition, VRS and 
NRS provide simple, efficient, and minimally intrusive measures of pain intensity and 
have been used widely in the clinical and research settings where a quick index of 
pain intensity is required and to which a numerical value can be assigned (77, 78). 
 
As seen in Figures 3.1A and 3.1B, the mean NRS and VRS pain scores obtained 
during the whole study period were rather similar between two treatment groups. 
Significant difference was only found at Day 3 after discharge from hospital. It is 
noted that, one patient (from the tramadol group) rated NRS and VRS as 9 and 4, 
respectively, for 3 days after discharge, was found with inflamed wound later on. This 
result has contributed to the significant difference in the NRS and VRS score between 
two treatment groups with wide standard deviation (SD) (P = 0.046, 0.038; SD = 
3.162, 1.356 for NRS and VRS respectively). If this particular result is excluded from 
the analysis, there will be no significant difference found in the NRS and VRS scores 
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between two treatment groups with smaller SD (P = 0.09, 0.084; SD= 1.902, 0.756 
for NRS and VRS, respectively). The rofecoxib group showed lower pain scores 
generally, except in the early postoperative period. However, no significant difference 
was detected at any of the assessment time-points. Although it was not established 
which treatment is superior, this study suggests that tramadol and rofecoxib showed 
comparable analgesic effects, which is further supported by similar consumption of 
rescue medications between the groups. 87% and 90% of patients described their pain 
at discharge time and at day 3 after surgery as ‘no pain’ or ‘no pain at rest, slight pain 
on movement’. Three patients revealed that they only felt pain during defecation, 
suggesting that majority of our patients received sufficient postoperative pain relief. 
All patients were discharged with a local anesthetic, lignocaine gel, which acts 
synergistically with the oral analgesic to relieve postoperative pain. This may affect 
the result to some extent, as pain relief is not solely due to the oral analgesic. 
 
Different methods of surgery may vary the intensity and perception of pain. In this 
study, either conventional or stapled haemorrhoidectomy was conducted. The method 
of haemorrhoidectomy used was determined at the discretion of surgeon and was 
beyond the consideration of this study. There was no difference in the anaesthetics 
used in both type of operations, which consisted of induction with propofol and 
maintained with isoflurane, nitrous oxide and oxygen. When the mean VRS and NRS 
scores of different surgery methods were compared, stapled haemorrhoidectomy had 
generally lower pain score (with the exception of 0.5 and 1 hour postoperation) 
compared with those of conventional haemorrhoidectomy (see Figures 3.2A and 
3.2B). However, no significant differences were detected at any point during the 
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whole study period. The surgical methods may play an important role in pain intensity, 
but it did not significantly affect the results in this study. Nonetheless, there was much 
smaller number of patients undergoing stapled haemorrhoidectomy (2/11) in the 
tramadol group compared to rofecoxib group (8/14). Stapled haemorrhoidectomy had 
generally lower pain scores if compared with that of conventional haemorrhoidectomy, 
this could contribute to the higher pain scores for tramadol on Day 3, since the 
number of patients undergoing stapled haemorrhoidectomy was fewer. 
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Figure 3.2A Time-effect curve for mean Numerical Rating Scale (NRS) pain scores 
for different methods of haemorrhoidectomy used. No significant difference was 
detected at any of the assessment points.  
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Figure 3.2B Time-effect curve for mean Verbal Rating Scale (VRS) pain scores for 
different methods of haemorrhoidectomy used. No significant difference was detected 
at any of the assessment points.  
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The symptoms presented or reported by patients postoperatively were nausea, nausea 
with vomiting, dizziness, hypotension, urinary retention, shivering, constipation, 
bloated and diarrhea. There was no complaint of respiratory depression or gastro-
intestinal upset from either groups of patients. Most of the patients complained about 
nausea or dizziness right after they roused out of general anesthesia at the recovery 
unit, and recovered spontaneously later on. Occasionally the feeling of dizziness may 
be continued until the second day after surgery. Some patients complained about 
nausea only after consumption of drink or food after the surgery. In the present study, 
the tramadol group was associated with a significantly higher incidence of nausea and 
dizziness; and a relatively higher incidence of nausea with vomiting and hypotension. 
54.5% of the patients who took tramadol preoperatively were found to be hypotensive. 
The incidence of hypotension was not investigated or reported in some other similar 
research (46, 79- 81), and is an issue worth investigating. Due to the high incidence of 
side effects observed, particularly nausea with vomiting and hypotension in the 
tramadol group, this study was terminated before a desired sample size could be 
reached. 
 
With its unique dual mechanism of action (weak opioid agonist, and noradrena line 
and 5-HT reuptake inhibitor), tramadol offers an alternative to other opioids, as these 
two complementary and synergistic actions enhance its analgesic effects and improve 
its tolerability profile (46). Both tramadol and rofecoxib are indicated for acute pain 
including postoperative pain; their difference in mechanism of action may be suitable 
for different patients. Tramadol may be particularly beneficial in patients for whom 
NSAIDs are not recommended or need to be used with caution, including patients 
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with peptic ulcers or those predisposed to them, those with hemorrhagic disorder or 
hypertension, and in patients with impaired renal, hepatic or cardiac function (46). 
Since selective COX-2 inhibitors do not appear to affect platelet aggregation or 
bleeding, it has been suggested that rofecoxib may offer some advantages in certain 
types of pain (e.g., surgical, dental) where bleeding is a potential complication (82).  
 
Recently, considerable attention has been focused on the concept of preemptive 
analgesia. Due to CNS plasticity, conscious perception of noxious stimuli is alleged to 
be modified by preoperative analgesic drug administration (74). Preemptive analgesia 
may prevent nociceptive inputs generated during surgery from sensitizing central 
neurons and, therefore, may reduce postoperative pain (82). Although more clinical 
studies have been conducted to evaluate the effectiveness of different analgesia in 
reducing postoperative pain and analgesic requirement, the result remains 
inconclusive (74, 83-85). The validity of preemptive analgesia as a routine clinical 
strategy can only be evaluated by more trials comparing the effectiveness of pre- or 
post-incision analgesia, and continuous or intermittent administration of analgesic 
drugs (74). 
 
Several limitations of this study are noted. The sample size recruited for this study 
was too small to allow generalized conclusion to be drawn. The number of patients 
undergoing stapled haemorrhoidectomy in the tramadol and rofecoxib group was not 
equivalent (2/11 vs. 8/14). The method of haemorrhoidectomy used in different 
patients may vary the intensity and perception of pain. In our study, stapled 
haemorrhoidectomy had generally lower pain scores if compared with that of 
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conventional haemorrhoidectomy, this could contribute to the higher pain scores for 
tramadol, since the number of patients undergoing stapled haemorrhoidectomy was 
fewer. The absence of a control group in this study makes it difficult to assess the pain 
relief immediately after the operation and any differences observed in side effects 
between groups were solely due to the preemptive study medication or from the intra-
operative analgesic and anesthetic agents administered. Future clinical studies can 
investigate the analgesic effects and safety profiles of different types of analgesics and 
their roles in preemptive analgesia. 
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This study represents the first in-depth report on the use of TCM for pain relief in 
Singapore. We hypothesized that TCM may play a more important role than just an 
alternative therapy in pain management in Singapore scenario. Our study objectives 
are to determine the prevalence of TCM use for pain relief, either as a first- line 
therapy or as an alternative to conventional analgesics and the patients’ beliefs of 
TCM, as well as, their perceptions of healthcare professionals’ attitudes and 
knowledge about TCM.  
 
4.2 Materials and Methods  
4.2.1 Subjects 
The questionnaire survey was carried out at a TCM practitioner clinic that issues 
TCM therapies (Chinese proprietary medicine (CPM) and acupuncture) and two 
polyclinics that prescribe and dispense conventional analgesics in Singapore. These 
two study locations provided the convenient samples of respondents which allowed 
comparison of the opinions and perspectives of patients seeking treatment from 
practitioners with different trainings and practices at the respective study sites. The 
subjects were patients who visited any of these clinics for consultation, age of at least 
18 years, who were prescribed conventional analgesic/s or diagnosed with any 
condition that was causing pain, English or Chinese language literate, and voluntarily 
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consented to participate in the study. For subjects attending the polyclinics, their 
prescriptions were screened at the polyclinic pharmacy. Prescriptions listing 
conventional analgesics like the NSAIDs, oral or external dosage forms, were tagged 
and the respective patients were approached. For those attending the TCM practitioner 
clinic, patients with diagnosis of existing conditions that caused pain, either acute or 
chronic, were informed by the TCM practitioner about our study and were approached 
after the consultation. Respondents were assured that all information divulged would 
be treated as confidential and used for research purpose only. 
 
4.2.2 Instrumentation  
A researcher-designed, self-administered, questionnaire was employed (Appendix IV).  
It was presented in both English and Chinese languages; respondents were allowed to 
choose to answer either version. It consisted of 27 questions which covered 5 sections: 
(a) basic demographic data; (b) information on the pain experienced (location, 
severity and frequency); (c) information on the used of TCM for pain relief; (d) 
information on the use of conventional medicines for pain relief; (e) general views on 
the use of TCM. Sections (c), (d) and (e) included questions pertaining to the usage of 
TCM or conventional medicine, perceived efficacy or side effect, cost, and their 
attitudes towards the use of TCM and conventional medicines. Only respondents who 
used TCM and/or conventional medicines for pain relief in the preceding 12 months 
were required to answer questions in sections (c) and/or (d). Filter questions were 
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The severity of pain in section (b) was assessed using the Verbal Rating Scale (VRS), 
which consists of a list of adjectives describing the different levels of pain intensity on 
a 5-point scale: no pain, mild pain, moderate pain, severe pain and very severe pain. 
The attitude questions of sections (d) and (e) in the Likert format were used to gauge 
respondents’ attitudes towards the use of conventional medicines and TCM. There are 
eight and ten items under the respective sections on attitude, with the options of 
“strongly disagree”, “disagree”, “not sure”, “agree” and “strongly agree”. The 
possible points ranged from 1 to 5, with 1 being most negative and 5 being most 
positive. Scores for negative statements were reversed (e.g. score 1 in a particular 
negative statement will be reversed to score 5) before further analysis so that the 
higher score reflects a more positive attitude. 
 
A pilot study was carried out before the actual survey, involving 16 respondents from 
among friends and colleagues. The pilot study tested the general comprehensibility of 
the questions and was a source of feedback for improvements to be made to the 
design of the questionnaire. Ambiguous or incomprehensible questions were 
rephrased. The results obtained from the pilot study were excluded from the actual 
analysis. 
 
4.2.3 Statistical analysis  
Computer software SPSS 11.0 for windows was employed in statistical analysis. The 
respondents were categorized either according to the location of survey (TCM 
practitioner clinic or polyclinic) or usage of TCM for pain relief for the preceding 12 
months (TCM user or non-user). Patients’ demographic data, prevalence of TCM use 
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and attitude scores of each group were analyzed using bivariate analysis (Chi-square 
test or t test as appropriate). The attitude scores among different age groups, at 
different education levels, and of different income levels were compared by analysis 
of variance (ANOVA). Logistic regression analysis was then conducted to determine 
the relative contributions of various characteristics to the individual TCM user or non-
user. Results were considered to be significant at a p-value of < 0.05. 
 
4.3 Results 
A total of 220 respondents from the three survey locations took part in this study: 100 
attended the TCM practitioner clinic, and 120 attended the two polyclinics. Among 
these, 6 questionnaires were excluded from further analysis because of the high 
percentage of incomplete questions (at least two sections out of five were not 
answered, which included the critical attitude questions), yielding a total of 214 
questionnaires, that is, 98 (45.8%) respondents attending the TCM practitioner clinic 
and 116 (54.2%) attending the  polyclinics. 
 
The basic demographic data of the respondents is shown in Table 4.1. There were 120 
(56.1%) female respondents, which made up a slight majority. The average age of the 
respondents was 38.8 years, ranged from 18 to 70, with the majority (69.6%) of age 
26 to 55 years. Most of the respondents were Chinese (80.4%). There were 13.6% of 
Malay respondents and about 6.1% of Indian and other races group. More than 80% 
of the respondents had at least attained secondary level education. A total of 35.5% 
had a monthly income below S$1000, 41.6% between S$1000 and S$3000, and 
16.4% above S$3000 and 6.5% did not report their monthly income. The breakdown 
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of the respondents’ demographic data according to the location of survey was also 
shown in Table 4.1. 
 
 
Table 4.1 Demographics Data of TCM survey 
All subjects   TCM user  
Characteristics TCM practitioner 
clinic, No. (%) 
Polyclinics 
No. ( %) 
Total 
No. ( %) 
 Total 
No. ( %) 
Gender      
Female 68 (69.4) 52 (44.8) 120 (56.1)  63 (62.4) 
Male 30 (30.6) 64 (55.2) 94 (43.9)  38 (37.6) 
Age (in years)      
18 – 25 5 (5.1) 37 (31.9) 42 (19.6)  8 (7.9) 
26 – 40 34 (34.7) 42 (36.2) 76 (35.5)  37 (36.6) 
41 – 55 44 (44.9) 29 (25) 73 (34.1)  43 (42.6) 
> 55 15 (15.3) 8 (6.9) 23 (10.8)  13 (12.9) 
Mean ± SD 43.83 ± 10.90* 34.63 ± 12.55 38.84 ± 12.66  42.26 ± 11.05 
Range 18-70 19-66    
Race/ethnicity       
Chinese 96 (98.0) 76 (65.5) 172 (80.4)  91 (90.1) 
Malay 1 (1.0) 28 (24.1) 29 (13.6)  7 (6.9) 
Indian 0 9 (7.8) 9 (4.2)  1 (1.0) 
Other 1 (1.0) 3 (2.6) 4 (1.9)  2 (2.0) 
Highest level of education      
Primary or below 27 (27.6) 8 (6.9) 35 (16.4)  25 (24.8) 
Secondary 46 (46.9) 63 (54.3) 109 (50.9)  49 (48.5) 
Tertiary or above 23 (23.5) 42 (36.2) 65 (30.4)  26 (25.7) 
Unknown 2 (2.0) 3 (2.6) 5 (2.3)  1 (1.0) 
Monthly income      
Less than S$1000 39 (37.8) 37 (31.9) 76 (35.5)  35 (34.7) 
S$1000 – S$2999 35 (35.7) 54 (46.6) 89 (41.6)  37 (36.6) 
S$3000 – S$5999 19 (19.4) 12 (10.3) 31 (14.5)  19 (18.8) 
> S$6000 1 (1) 3 (2.6) 4 (1.9)  3 (3.0) 
Unknown 4 (4.1) 10 (8.6) 14 (6.5)  7 (6.9) 
* p < 0.05 
 
 




Table 4.2 Information related to pain experience 
Characteristic TCM practitioner clinic, No. (%) 
Polyclinics 
No. (%) Total, No. (%) 
Areas of body in pain*    
Back 31 (17.8) 40 (19.3) 71 (18.6) 
Head 26 (14.9) 36 (17.4) 62 (16.3) 
Shoulder 21 (12.1) 22 (10.6) 43 (11.3) 
Arm (included hand and wrist) 21 (12.1) 22 (10.6) 43 (11.3) 
Ankle and foot 17 (9.8) 26 (12.6) 43 (11.3) 
Chest and stomach 25 (14.4) 17 (8.2) 42 (11.0) 
Knee 20 (11.5) 14 (6.8) 34 (8.9) 
Neck 9 (5.0) 23 (11.1) 32 (8.4) 
Others 4 (2.3) 7 (3.4) 11 (2.9) 
Severity of pain    
Mild pain 35 (35.7) 28 (24.1) 63 (29.4) 
Moderate pain 41 (45.6) 49 (42.2) 90 (42.1) 
Severe pain 11 (11.2) 27 (23.3) 38 (17.8) 
Very severe pain 2 (2.0) 5 (4.3) 7 (3.3) 
Unknown 9 (9.2) 7 (6.0) 16 (7.5) 
Number of areas in pain    
Pain in one area 47 (48.0) 63 (54.3) 110 (51.4) 
Pain in two areas 28 (28.6) 25 (21.6) 53 (24.8) 
Pain in more than two areas 18 (18.4) 26 (22.4) 44 (20.6) 
Unknown 5 (5.1) 2 (1.7) 7 (3.3) 
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Table 4.2 shows the overall and breakdown (according to location of survey) 
information related to respondents’ pain experiences. The anatomical areas with pain 
were the back (18.6%), followed by the head (16.3%), shoulder, arms and ankle/foot 
(11.3%). Most rated the severity of their pain as ‘moderate’ (42.1%) or ‘mild’  
 (29.4%), and only 7 respondents (3.3%) rated it as ‘very severe’. About 45.4% of the 
respondents experienced pain in two or more areas of the body and with four 
respondents indicating that pain was experienced in up to 6 different areas of their 
bodies. 
 
Out of the 214 respondents, 101 (47.2%) indicated that they had used TCM for pain 
relief in the preceding 12 months (TCM user), and of these 70 were under the care of 
the TCM practitioner and 31 of them were polyclinic patients. The characteristics that 
were found to be significant for predicting whether the respondent is a TCM user or 
non-user, were location of survey, age range, racial, and education level. Further 
logistic regression indicated that the location of survey was the only item significantly 
related to use or non-use of TCM. There was significantly more TCM users from 
TCM practitioner clinic than that from polyclinic. Most of the TCM users was of the 
ages 26-55 (79.2%). It was found that the percentage of respondents, who were TCM 
users, increased with age, that is, 19%, 49%, 59% and 57% of those aged 18-25, 26-
40, 41-55 and more than 55 years, respectively.  This suggests that TCM was more 
popular in the middle-aged and older aged groups. Majority of the TCM users was 
Chinese and a minority (10%) was non-Chinese. Out of these 101 TCM users, 54 
(53.5%) tried conventional medicines for pain relief prior to switching to TCM. In 
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other words, 47 (46.5%) TCM users had used TCM as a first- line pain relief in the 
preceding 12 months. 
 
Table 4.3 summarizes the types of TCM used and the reasons for using TCM for pain 
relief. Of the treatments listed in the questionnaire, oral CPM was the most frequently 
cited treatment for pain relief by 74.7% of the 101 TCM users, followed by CPM for 
external application (31.3%), Chinese massage therapy (28.3%), acupuncture (25.3%) 
and raw herbs (20.2%). When asked about the reasons for using TCM for pain relief, 
the most common cited by 38 (55.9%) out of 68 respondents from TCM practitioner 
clinic was ‘TCM is more effective than Western medicine’. However, for TCM users 
from polyclinics, ‘TCM was recommended by friends or family’ was the most 
common reason given (21, 67.7%). About 32% respondents indicated that ‘TCM has 
fewer side effects than Western medicine’.  The overall reported efficacy of TCM for 
pain relief was 91.1% (92 out of 101). However, seven (22.7%) out of 31 respondents 
from polyclinic indicated that the TCM treatments tried were ineffective, which was 
significantly higher than the other group (2.9% stated as not effective). Nevertheless, 
only one respondent from TCM practitioner clinic reported a side effect after using 
TCM, which was stated as ‘stomachache’.  
 
 




Table 4.3 Types of TCM treatments used for pain relief and the reasons 
Treatment (N = 99)* 
TCM 
practitioner 
clinic (N = 68) 
Polyclinic 
(N = 31) 
Total  
(N = 99) 
    
CPM for oral consumption 57 (83.8) 17 (54.8) 74 (74.7) 
CPM for external application 17 (25.0) 14 (45.2) 31 (31.3) 
Chinese massage therapy 16 (23.5) 12 (38.7) 28 (28.3) 
Acupuncture 15 (22.1) 10 (32.3) 25 (25.3) 
Raw herbs 15 (22.1) 5 (16.1) 20 (20.2) 
    
Reason (N=99)*    
    
TCM is more effective than Western 
medicines 38 (55.9) 6 (19.4) 44 (44.4) 
TCM was recommended by friends 
or family 22 (32.4) 21 (67.7) 43 (43.9) 
TCM has fewer side effects than 
Western medicines 25 (36.8) 6 (19.4) 31 (31.6) 
TCM is reasonably priced 6 (8.8) 3 (9.7) 9 (9.1) 
TCM is easily accessible 3 (4.4) 3 (9.7) 6 (6.1) 
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4.3.1 Use of conventional medicines for pain relief 
Patients who indicated that they had used conventional medicines for pain relief in the 
preceding 12 months were required to answer questions related to the use of 
conventional medicines for pain relief in section (d). This group of patients (122 out 
of a total of 214) was prescribed analgesics like paracetamol (alone or with low dose 
opioid analgesic), NSAIDs, or a muscle relaxant for pain relief.  
 
An 8-item Likert format question was used in section (d) to investigate the 
respondents’ attitudes towards the use of conventional medicines to treat pain 
problem (Table 4.4). The scoring system for these items was designed such that the 
higher score indicates a more positive attitude. When the respondents were 
categorized according to the location of survey, polyclinic patients score significantly 
higher than that of TCM practitioner clinic’s patient for statements 2, 3, 7 and 8 (P = 
0.02, 0.03, 0.02 and 0.02). When the respondents were re-categorized into TCM users 
and non-users, significant differences were found between the groups for statements 2, 
3 and 8 only (P =0.022, 0.001 and 0.032).  These results suggest that, the respondents 
from polyclinic and those TCM non-users had more positive perceptions than the 
respective counterparts that conventional medicines are effective in relieving pain, 
giving minimal side-effects with reasonable price. Moreover, polyclinic patients had 
higher confidence in conventional medicines for pain even if there is little research 
done to prove their effectiveness and safety. 
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Table 4.4 Mean scores for statements on the use of conventional medicines and for statements 
on the general use of TCM 
Mean Score 
Attitude statements towards the use of conventional medicines 






TCM user  
TCM 
nonuser  
1. I feel less pain after taking the medicine. 3.56 3.82  3.59 3.81 
2. The medicine is effective. I feel no pain after I take the 
medicine for 2 days or more. (Reversed) 
2.82* 3.46  2.92* 3.39 
3. I feel better after taking the medicine and experience no 
side effects like stomach discomfort. (Reversed) 
3.18* 3.76  3.12* 3.82 
4. I am aware of the possible side effects that I may 
experience while taking the medicine. 
3.54 3.19  3.47 3.24 
5. I do not find taking the medicine at fixed timings (e.g. 
morning, noon and night) troublesome. (Reversed) 
3.16 3.22  3.10 3.27 
6. I stop taking the medicine regularly every day when I 
don’t feel any pain. (Reversed) 
3.78 3.76  3.78 3.76 
7. I will still take Western medicines for pain relief even if 
there is little research done to prove their effectiveness 
and safety. 
2.60* 3.22  2.75 3.12 
8. The price of Western medicines for treatment of my pain 
is reasonable. 
2.74* 3.4  2.86* 3.31 









2. Traditional Chinese medicines are more effective than 









4. The recent Slim 10 issue (86) has not made me doubt the 




5. I will still take traditional Chinese medicines even if 





6. When asked by the pharmacist/Western doctor, I am 





7. I see the need for the pharmacist/Western doctor to 





8. I feel that the pharmacist/Western doctor agrees with the 
use of traditional Chinese medicines for the treatment of 




9. I feel that the pharmacist/Western doctor is 





10. I would approach a pharmacist/Western doctor to find 





* p < 0.05 
1= strongly dis agree; 2= disagree; 3= not sure; 4= agree; 5= strongly agree.
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No significant difference was found between males and females on their attitude 
scores. ANOVA test failed to show differences among respondents of different age 
groups, education levels and income levels. 
 
4.3.2 General views on the use of TCM 
Section (e) aims to examine the respondents’ general views on the use of TCM. All 
respondents would be required to answer questions in this section. When asked if they 
would use TCM first before consulting the Western medical practitioner or trying 
conventional medicines for treatment of any illness, 57 (26.6%) indicated that they 
would use TCM first and 144 (67.3%) indicated that they would not. Out of the 
former 57 respondents, 37 (64.9%) of them were from the TCM practitioner clinic, 
and 43 (75.4%) of them were TCM user. This suggests that patients from TCM 
practitioner clinic and those who tried TCM before would be more likely to use TCM 
as first- line therapy when they were sick than their counterparts (p < 0.05 for both 
cases). 
 
A group of 39 (18.2%) out of 214 respondents stated that they were currently taking 
both TCM and Western medicine for pain relief. Of these, 28 (71.8%) of them were 
TCM users. This suggests that respondents who used TCM before were more likely to 
take both kinds of medicines for pain relief than the TCM non-users (p < 0.05). 
 
A 10-item Likert format question was used in this section to examine the respondents’ 
general attitudes towards the use of TCM (Table 4). When the respondents were 
categorized according to the location of survey, the group from TCM practitioner 
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clinic had a significantly higher score than that from the polyclinic group for 
statements 1, 2, 4 and 5 (P = 0.001 for all four statements); whereas polyclinic group 
had a significantly higher score for statements 7-10 (P = 0.023, 0.004, 0.006 and 
0.001 respectively) . The respondents were then re-categorized into TCM users and 
TCM non-users; TCM user score significantly higher than that of TCM non-user for 
statements 1, 2, 4 and 5 (P = 0.001 for all four statements); whereas TCM non-users 
score significantly higher for statements 7-10 (P = 0.033, 0.001 and 0.014). 
 
The results above suggest that, the respondents from TCM practitioner clinic and 
those who were TCM users have fewer concerns about the safety and efficacy of 
TCM than their counterparts. They showed more confidence in TCM even if there is 
little research done to prove their effectiveness and safety. But, all respondents 
(regardless of grouping) had more negative perceptions that concurrent use of TCM 
and conventional medicine is safe; and indicated that they would inform their 
pharmacists or doctors that they were using TCM only if they were asked. On the 
other hand, respondents from polyclinics and TCM non-users were more willing to 
inform the pharmacist/doctor that they are using TCM. They also felt that these 
healthcare professionals would support their use of TCM and they would be more 
inclined to approach them to find out if it would be safe to consume TCM and 
conventional medicines together. However, all respondents felt that 
pharmacists/doctors have limited knowledge of TCM. 
 
No significant difference was found between males and females on their attitude 
scores towards the general opinion of TCM. ANOVA test failed to show differences 
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The prevalence of TCM use for pain relief in the preceding 12 months by the study 
subjects was approximately half (47%, 101/214), with oral CPM representing the 
most popular choice. It was found that most of the TCM users were from the middle 
to old age-group, and majority of them was Chinese. This finding is consistent with 
other studies that older respondents were more likely to use TCM/CHM (87, 88). It has 
been suggested that TCM/CHM use was significantly associated with the presence of 
chronic medical conditions, such as rheumatism, lower back pain or cancer, which are 
more prevalent in elderly. This is also within the inclusion criteria for pain-related 
problems of our survey thus contributing to our results.  
 
Half (53.5%, 54/101) of the TCM users identified tried conventional medicines for 
pain relief prior to TCM, whereas the other half (46.5%, 47/101) used TCM as a first-
line treatment for pain. This figure implies that the role of TCM in Singapore is far 
more than a complementary or alternative medicine, but is one of the mainstream 
therapies, integrated into daily lives. These findings may be very different from that 
of Western or European countries, where TCM remains a complementary medicine; 
but is believed to be similar to other Asian countries with substantial Chinese 
populations. Taking Hong Kong as example, the use of TCM has been a long practice 
in Hong Kong. It has been reported that, about 13.5% of the randomly selected 
sample had been using TCM drugs frequently or occasionally (87). Respondents who 
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attended the TCM practitioner clinic and TCM users had a more positive orientation 
towards TCM, were more confident about the safety and efficacy of TCM. This 
perception may be due to their past experiences with TCM, which were positive with 
minimal side effects. Despite having a highly perceived efficacy, concerns associated 
with the use of TCM, especia lly CHM, remain.  This finding is similar to other studies 
where respondents perceived CHM as “milder and does not have as strong side effects 
as Western medicine” (89). Although it is true that CHM comes mainly from plants 
that is a natural source, but the ‘natural source’ should not be taken as equal to ‘milder, 
less toxic or free from adverse effect’. The adverse effects of CHM include the 
toxicity of the herbs itself and the toxic effects due to the contaminants. A number of 
toxic herbs are still commonly used in CHM. Kam and Liew (90), in their review 
article, reported adverse effects of CHM involving the cardiovascular, neurological, 
gastrointestinal, hematological and renal systems. The other area of concern is the 
adulteration or contamination of CPM as outlined in Koh and Woo’s review (91) on the 
presence of excessive toxic heavy metals and undeclared drugs in CPM in Singapore 
between 1990 and 1997. Among the 2080 CPMs screened, 42 were found to contain 
excessive amounts of arsenic, copper, lead and mercury; and 32 had adulterants of 19 
conventional drugs (which includes antihistamine, NSAIDs, analgesic antipyretics, 
corticosteroid etc.). Hence, new regulations on the control of CPM were enforced in 
Singapore on September 1999, which included the licensing and labeling 
requirements and control of microbial contamination. The adverse effects of CHM 
may be associated with hypersensitivity reactions, resulting from long-term use at 
inappropriate dosage levels (92). Therefore the public needs to be informed about the 
importance of consulting a qualified and experienced TCM practitioner, and should 
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refrain from self-medicating freely with CHM or CPM, which may delay the 
treatment and lead to further complications of the illness.  
 
It was found that all respondents were more negative regarding the statement ‘it is 
safe to use both TCM and conventional medicine together’. It suggests that the 
respondents might be aware of the potential risk involved with the concurrent use of 
TCM, especially CHM/CPM, and conventional medicine. Nevertheless, some 18% of 
respondents revealed that they were taking both kinds of medicine for pain relief at 
the time of the study. Besides, it may be common for patients, especially those with 
chronic diseases or cancer, to take both conventional medicine and complementary 
medicine (be it CHM or other therapy) together. This may expose them to the 
potential interactions between the complementary and conventional medicines. The 
interactions between CHM and both warfarin and digoxin are widely reported (90, 93-95). 
The anticoagulant effect of warfarin can be potentiated by Danshen and Dong Quai 
(Angelica sinensis); and ginseng has been shown to decrease the effect of warfarin 
and to increase digoxin levels. 
 
This study showed that most of the respondents were willing to inform to their 
doctor/pharmacist that they were using TCM when asked. Some respondents, 
especially those from the TCM practitioner clinic, do not see the need for the 
conventional healthcare provider to be informed that they are using TCM. This group 
also thought that their doctor/pharmacist would not approve of the use of TCM. 
Therefore it is unlikely that patients would take the initiative to discuss this issue with 
the pharmacist/doctor. It is important for the healthcare professional to establish 
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relationships that allow effective communication with the patients (89) and to reassure 
the patients that the aim is not to reprimand them for bad health practices, but to offer 
useful information on the management of health conditions (95). Then patients who 
have concerns about their treatments can surface and discuss them with their 
doctor/pharmacist in order to avoid adverse events and any potential interaction.  
 
For the pharmacist/doctor to be able to advise their patients on the use of CHM, they 
need to be well- informed. Knowledge regarding the benefits, limitations and side 
effects of CHM would be useful, and more importantly, the possible interactions 
between conventional and traditional medicines (95).  Limited knowledge on TCM 
often breeds fear that all such treatments would yield more risks than benefits to the 
patients. All our respondents felt that the doctor/pharmacist have limited knowledge 
of TCM. Another study also found that fellow doctors had the same knowledge level 
as the patients on TCM (96). This raises the need to incorporate knowledge of TCM in 
the curricula of the pharmacy and medical undergraduate programs or as continuing 
education for healthcare practitioners. TCM and conventional medicine independently 
employ very different approaches of treating disease, from the basic theories and 
concepts, to the therapeutic principles and the corresponding treatments.  
 
Several limitations to this study are noted. As the questionnaire was designed for self-
administration, patients who were illiterate were unable to answer the questionnaire 
by themselves, and thus were excluded from the study. They were mainly the elderly 
and some foreign workers. The exclusion of the elderly group of patients might have 
resulted in the loss of a substantial number of patients who were susceptible to pain 
and aches, and who were more likely to use TCM as suggested by another study (55). 
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Some respondents commented that the questionnaire was too lengthy; especially the 
two Likert format questions which involved 8 and 10 items, that they had no time to 
read the statements carefully, leaving some questions unanswered. There were also 
problems with language and translation of the questionnaire. The translated Chinese 
version may not be absolute similar to the English version although efforts were made 
to ensure that the same meanings were conveyed. This could have led to 
misinterpretation of the questions.  
 
This study allows for a better understanding of some types of TCM treatment in 
Singapore. Some areas of concern associated with TCM use, such as the lack of 
awareness about the safety of CHM, as well as, the cautions needed for the concurrent 
use of CHM and conventional medicine have been highlighted. As the healthcare 
professionals and their patients become more knowledgeable and aware of possible 
adverse reactions and complications that can arise from these treatments, overall 
patient safety can be further enhanced. 
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Chapter V – Conclusion  
 
Pain is a very common complaint presented by patients, and it represents the most 
commonly perceived symptom which has an enormous impact on public health which 
is worthy of more attention. There are many modalities that can be used in pain 
management; nonetheless, drug treatment remains, for the most part, the cornerstone of 
treatment. While opioids remain an integral part of pain-management strategies, there is 
now an emphasis on the use of adjuvant drugs, such as NSAIDs, COX-2 inhibitors and 
tramadol, which acts through different mechanisms. On the other hand, traditional, 
complementary and alternative medicines are becoming increasingly popular 
throughout the world and gaining greater acceptance in the healthcare system. TCM, a 
kind of traditional medicines which is popular in local setting, is believed to have a part 
to play in pain management. The three different studies described in previous chapters 
look into various aspects in pain management, namely the concept of “preemptive 
analgesia” in postoperative pain management, and the role TCM in acute or chronic 
pain management in a local scenario. 
 
The preemptive analgesic effects of celecoxib, etoricoxib, indomethacin, naproxen and 
tramadol in a rat model of incisional pain were studied by comparing the withdrawal 
thresholds and cumulative pain scores between the control, preoperative and 
postoperative groups which were administered with different drugs. The findings 
showed that animals that were given preoperative administration of these 5 drugs 
exhibited significantly higher withdrawal thresholds than that of the placebo control 
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group. Moreover, the effects of preoperative administration of etoricoxib, indomethacin, 
naproxen and tramadol were significantly higher compared to that of postoperative 
administration of the corresponding drug for a period up to 2 days after the surgery. 
The preemptive analgesic effects of these five drugs in animal work are encouraging, 
and future studies on the combination of preemptive analgesia and multimodal 
analgesic strategy, multi-dose regimen trial and randomized controlled clinical trial will 
be needed to corroborate the clinical relevance of preemptive analgesia. 
 
The analgesic efficacies and safety profiles of preoperative rofecoxib and preoperative 
tramadol in patients undergoing haemorrhoidectomy were studied at an ambulatory 
surgical centre. Both rofecoxib and tramadol showed comparable analgesic efficacy in 
this study.  However, tramadol was associated with a higher incidence of side effects. 
Future clinical trials with proper study design will be needed to investigate both the 
analgesic efficacy and safety profiles of different types of analgesic s and their roles in 
preemptive analgesia. The idea of preemptive analgesia is attractive, if it is proven to be 
clinically sound, improvement in patient comfort, decrease in postoperative morbidity 
and potential healthcare saving could then be anticipated. 
 
In Singapore, conventional medicine is still the orthodox therapy which is endorsed by 
the national healthcare institutions. Nevertheless, the results from this survey reveal 
that the use of TCM to treat pain problem is prevalent, with substantial of them, 
especially the ethnic Chinese, using TCM as first- line therapy. The survey revealed that 
the total prevalence of TCM use for pain relief in the preceding 12 months by the study 
subjects was 47%. A 46.5% of these TCM-users used TCM as the first-line treatment 
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for pain relief, suggesting that TCM is more than just an alternative medicine in 
Singapore, and perhaps in other countries where the ethnic Chinese lives, although 
further study is required to conclude these. This study seeks to understand aspects of 
TCM treatment in Singapore. The results also revealed areas of concern associated with 
TCM use, safety being the main priority. More research needs to be conducted to 
establish the potential risks arising from interactions between the concurrent use of 
CHM and conventional medicines. Pharmacovigilance efforts and directions should be 
expanded to include TCM treatments so that the evidence of safety and risk with East-
West combination treatments can be gathered expediently over time. Moreover, greater 
effort towards public education on the safety and efficacy of the use of TCM is 
warranted. Doctors and pharmacists should be further equipped with relevant 
knowledge in order to provide education and information to patients 
 
Several limitations in these studies were noted. The relatively small sample size and the 
convenient samples that involved in the clinical study and the questionnaire survey 
have limited their generalisability to represent the population at large.  In order to draw 
conclusions that apply to general population, a representative sample with large enough 
sample size from this study population would be required. Bias is one of the main 
concerns in any clinical trial. Both the animal and clinical studies described were not 
double blinded; investigator bias could have been introduced during the data collection 
and assessment stage. In the animal study, the parameters used in clinical appearance 
investigation of the rats are always subjective and varies considerably. The signs of 
pain may be very subtle and strongly depends on the experience of the investigator. The 
investigators bias would impose some limitation to our study. Future study with proper 
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study design, preferably double blind study with representative sample size, would be 
required to avoid potential problems of bias. No pharmacoeconomic analysis was done 
in any of our studies. It would be interesting to involve cost-effectiveness study of 
various treatments in a future study, for example, preemptive analgesic treatment 
versus postoperative analgesic treatment among different drugs; and TCM versus 
conventional treatment. The pharmacoeconomic information will be precious in 
determining the most efficient and economic treatment in pain management. 
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Appendix I – Numerical Score Sheet for Pain Study Using Rat Model 
 
Date:    Time:   Day: 
Group:                                / ID 1 2 3 4 5 6 
Parameter        
Weight bearing* 1 (0-2)       
Weight bearing 2 (0-2)       
Weight bearing 3 (0-2)       
Body weight score† (0-3)       
Eyelid closure‡ (0-2)       
General grooming (0-2)       
Ocular/nasal discharge (0-2)       
Vocalization (0-2)       
Biting/licking wound (0-2)       
Overall activity (0-2)       
Provoked activity (0-2)       
Diarrhea/abnormal discharge (0-2)       
Total pain score (0 - 25)       
 
* Weight bearing score:  
Each animal was closely examined for a period of 1- minute and scored accordingly. 
The observation was then repeated twice with a 3-5 minute test-free period between 
each trial.  
0 – Full weight bearing of the foot, the wound was blanched or distorted by the mesh;  
1 – Half weight bearing, the would touched the mesh without blanching or distorting; 
2 – No weight bearing, the foot was completely off the mesh; 
 
† Body weight score:  
0 – Normal, less than 5% weight loss  
1 – 5-10% weight loss   
2 – 11-20% weight loss 
3 – More than 20% weight loss 
 
‡ For other parameters: 
0 – Normal 
1 – Minor abnormalities 
2 – Serious abnormalities 
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Appendix II – Numerical Rating Scale (NRS) 
 
 
Numerical Rating Scale (NRS) 
 
Please indicate the number that best corresponds to the pain 







 Worst possible 
pain 
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Appendix III – Verbal Rating Scale (VRS) 
 
Verbal Rating Scale (VRS) 
 
Please indicate which of the following categories most closely 




? ?  
Tidak ada kesakitan 
No pain at rest, slight pain on movement 
? ? ? ? ? ,  ? ? ? ? ? ? ?  
Tidak ada kesakitan ketika berehat, sedikit kesakitan ketika 
bergerak 
Slight pain at rest, moderate pain on movement 
? ? ? ? ? ? ? ,  ? ? ? ? ? ? ?  
Sedikit kesakitan ketika berehat, kesakitan yang sederhana 
ketika bergerak 
Moderate pain at rest, severe pain on movement 
? ? ? ? ? ? ? ,  ? ? ? ? ? ? ?  
Kesakitan yang sederhana ketika rehat, kesakitan yang 
keterlaluan ketika bergerak 
Severe pain at rest and on movement 
? ? ? ? ? ? ? ? ? ? ?  
Kesakitan yang keterlaluan ketika rehat dan ketika bergerak 
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The National University of Singapore is conducting a survey to study the use of traditional Chinese 
medicines for pain relief and the opinions of the public on the use of traditional Chinese medicines in 
general.  
 
We would like to invite you to participate in this survey by completing the following questionnaire. 
The questionnaire consists of 27 questions and would take approximately 15 minutes to complete. If 
you agree to participate in this survey, please be assured that all information received will be strictly 
confidential and used purely for research purposes. 
 





Location of survey :    
 
 
A.  Personal Details 
Please fill in your name, occupation and year of birth in the space provided.  
 
1.  Initials of your name :       
2.  Occupation :        
3. Year of birth :       
  
Please tick the most appropriate choice: 
4. Gender 
 Male  Female 
 
5. What is your ethnicity? 
 Chinese  Malay 
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6.  What is your highest level of education attained? 
 Primary  Pre-university/Junior college 
 Secondary  Tertiary 
 Polytechnic   No formal education 
 Others:      
                  (Please specify) 
 
7. What is your monthly income? 
 Less than S$1000 S$3000 – S$5999 
 S$1000 – S$2999 S$6000 and above  
 
8. Which language do you normally speak (at home, with family and friends, etc)? 
 English  Mandarin 
 Malay  Tamil    
 Chinese dialect  Others:     
 (E.g. Hokkien,                 (Please specify) 
 Teochew, Cantonese, etc)  
 
 
B. About your pain 
 
9. In which part of your body do you experience pain? (You may tick more than once) 
Head/Forehead  Face 
 Shoulder  Wrist 
 Joints of fingers Elbow    
 Back   Abdomen 
 Thigh  Knee     
 Feet   Ankle 
     (including the sole)                 In the neck  
      Others:     
              (Please specify) 
        
10. How severe is your pain? 






Please tick the most appropriate choice for the following questions:  
11. Do you feel the pain almost everyday or every other day?  
 Yes  (If Yes, please go to question 12) 
 No  (If No, please go to question 13) 
Very severe 
pain Severe pain No pain Mild pain Moderate pain 
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12. For how long have you been feeling the pain?  (Please fill in your answer in the space 
provided) (E.g. For weeks, months or years) 
             
          _____________ 
 
13. What was the cause of your pain? (Please fill in your answer in the space provided) 
 (E.g. Operation/surgery, injury from work, fell down, etc) 
            
          _____________ 
 
14. Did you use any traditional Chinese medicine in the past 12 months  for pain relief? 
 Yes  (If Yes, please go to question 15) 
 No  (If No, please go to question 21) 
 
 
C.    Use of traditional Chinese medicine for pain relief 
 
In this survey, traditional Chinese medicine refers to raw herbs, ready-made herbal 
products for oral consumption or external use, acupuncture and massage therapy used in 
the system of therapeutics according to traditional Chinese method. 
Ready-made products refer to patent herbal products either for oral consumption or 
external use, and medicated plasters with herbal ingredients. 
 
15. What type(s) of traditional Chinese medicine have you used for pain relief? 
 (You may tick more than once) 
 Raw herbs  Ready-made medicine for oral consumption 
      Acupuncture Ready-made medicine for applying on the skin 
      Massage therapy                                              skin (E.g. Liniments, creams, herbal plasters) 
 Others:   
                               (Please specify) 
  
16. Is the traditional Chinese medicine you have used effective in pain relief?  
 Yes   
 No   
 
17. Did you feel worse in any way after using the traditional Chinese medicine? 
 Yes   
 No   
  
 If Yes, can you describe how you felt?       
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Note:  Western medicine includes orally taken preparations like tablets and liquid syrups , and 
externally applied ones like creams, ointments, gels and medicated plasters (E.g. Tokuhon, 
Salonplas).  
 
18. What are your reasons for using traditional Chinese medicine for pain relief? 
 (You may tick more than once) 
 Easy to buy Chinese medicine  Traditional Chinese medicine has less side 
 Recommended by friends or family effects than Western medicine 
 Reasonably priced  Chinese medicine is more effective than  
 Others:   Western medicine  
  (Please specify) 
 
19. How much do you spend each month on traditional Chinese medicine for pain relief? 
 Less than S$10 S$10 – S$25 
 S$26 – S$45  More than S$45 
 
20. Before  using traditional Chinese medicine, did you see a Western doctor or use any Western 
medicines for pain relief? 
 Yes  (If Yes, please go to question 22) 




D. Use of Western (conventional) medicine for pain relief 
 
21. In the past 12 months , have you seen a Western doctor or used any Western medicine(s) for 
pain relief? 
 Yes  (If Yes, please go to question 22) 
 No  (If No, please go to question 25) 
 
22. What Western medicine(s) have you used for pain relief? 
        
        
 
23. How much do you spend each month on Western medicine(s) for pain relief? 
 Less than S$10 S$10 – S$25 
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24. Below are some statements about the treatment of pain using Western medicine . Please read 








1) I feel less pain after taking the medicine. 1 2 3 4 5 
2) The medicine is ineffective. I still feel the 
pain even after I take the medicine for 2 
days or more. 
1 2 3 4 5 
3) I feel worse after taking the medicine 
because of side effects like stomach 
discomfort. 
1 2 3 4 5 
4) I am aware of the possible side effects 
that I may experience while taking the 
medicine. 
1 2 3 4 5 
5) I find taking the medicine at fixed 
timings (e.g. morning, noon and night) 
troublesome. 
1 2 3 4 5 
6) I take the medicine regularly every day 
even when I don’t feel any pain. 1 2 3 4 5 
7) I will still take Western medicines for 
pain relief even if there is little research 
done to prove their effectiveness and 
safety. 
1 2 3 4 5 
8) The price of Western medicines for 
treatment of my pain is reasonable. 




E. General views on the use of traditional Chinese medicine 
 
25. Do you usually use traditional Chinese medicine first before seeing a Western doctor/use 
Western medicine for any illness you have? 
 Yes   
No   
 
26. Are you currently taking both Western and traditional Chinese medicine for pain relief? 
 Yes   








27. Below are some possible opinions  that the general public may have about the use of traditional 
Chinese medicine . Please read the statements carefully and circle the number that best 
describes how you feel. 
 





1) Traditional Chinese medicines are safer 
than Western medicines. 1 2 3 4 5 
2) Traditional Chinese medicines are 
more effective than Western 
medicines for treating illnesses. 
1 2 3 4 5 
3) It is safe to use both traditional Chinese 
and Western medicines together. 
1 2 3 4 5 
4) The recent Slim 10 issue has made me 
doubt the safety of traditional Chinese 
medicines. 
1 2 3 4 5 
5) I will still take traditional Chinese 
medicines even if there is little 
research done to prove their 
effectiveness and safety. 
1 2 3 4 5 
6) When asked by the pharmacist/Western 
doctor, I am unwilling to say that I am 
taking traditional Chinese medicines. 
1 2 3 4 5 
7) I see no need for the 
pharmacist/Western doctor to know 
that I am taking traditional Chinese 
medicines. 
1 2 3 4 5 
8) I feel that the pharmacist/Western 
doctor disagrees with the use of 
traditional Chinese medicines for the 
treatment of any kind of illness. 
1 2 3 4 5 
9) I feel that the pharmacist/Western 
doctor knows very little about 
traditional Chinese medicines. 
1 2 3 4 5 
10) I would approach a 
pharmacist/Western doctor to find out 
if I can take both Western and 
traditional Chinese medicines together. 




-- END --  
